| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | NCOA6 SP3 ESR2 ASH1L SREBF2 KDM4E BAP1 TRIM66 NFATC3 SUPT6H HNF1A RNF169 ZEB1 EP400 RBL2 BRD3 REST MLLT10 NCAPH PBRM1 SBNO1 SMARCA2 MBD5 HCFC1 KDM1A | 5.57e-06 | 739 | 247 | 25 | GO:0003682 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SP3 SP4 POU6F2 ZNF549 ESR2 SREBF2 ZKSCAN7 ZEB2 HOXC6 NFATC3 NFYA NFYB ZNF264 USF2 HNF1A ZEB1 NRF1 REST RFX1 CREM E2F8 ZNF711 PKNOX2 FOXP4 ARNT DACH2 TET1 GMEB1 ATF1 HCFC1 KDM1A ZNF646 | 6.90e-05 | 1244 | 247 | 32 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SP3 SP4 POU6F2 ZNF549 ESR2 SREBF2 ZKSCAN7 ZEB2 HOXC6 NFATC3 NFYA NFYB ZNF264 USF2 HNF1A ZEB1 NRF1 REST RFX1 CREM E2F8 ZNF711 PKNOX2 FOXP4 ARNT DACH2 TET1 GMEB1 ATF1 HCFC1 KDM1A ZNF646 | 1.03e-04 | 1271 | 247 | 32 | GO:0000987 |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 1.49e-04 | 9 | 247 | 3 | GO:0015379 | |
| GeneOntologyMolecularFunction | PLC activating G protein-coupled glutamate receptor activity | 1.52e-04 | 2 | 247 | 2 | GO:0001639 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 3.79e-04 | 12 | 247 | 3 | GO:0008519 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA6 SP3 ABL1 ESR2 ASH1L SREBF2 ZEB2 MET KMT2C TSC22D1 ADRB2 NFATC3 SUPT6H SQSTM1 NFYA NFYB TAF4 USF2 MED13 HNF1A ZEB1 NRF1 APBB2 BRD3 REST MLLT10 CREM E2F8 ZNF711 ARNT ARID2 MDC1 TET1 SMARCA2 GMEB1 LRP5 ATF1 HAMP HCFC1 KDM1A GABPB1 ZNF646 | 2.84e-08 | 1390 | 248 | 42 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | ABL1 UBQLN4 KDM4E MET SUPT6H KHDC3L NFRKB KCNK2 FGFR4 TAF4 RNF169 EP400 CCT7 APLF E2F8 PBRM1 ARID2 SMARCA2 ATF1 HDAC10 KDM1A IL7R | 1.41e-06 | 564 | 248 | 22 | GO:0051052 |
| GeneOntologyBiologicalProcess | regulation of DNA repair | ABL1 UBQLN4 KDM4E KHDC3L NFRKB TAF4 RNF169 EP400 PBRM1 ARID2 SMARCA2 HDAC10 KDM1A | 5.52e-06 | 234 | 248 | 13 | GO:0006282 |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | ABL1 UBQLN4 KDM4E KHDC3L RNF169 EP400 PBRM1 ARID2 SMARCA2 KDM1A | 1.12e-05 | 146 | 248 | 10 | GO:2000779 |
| GeneOntologyBiologicalProcess | hypotonic response | 1.86e-05 | 14 | 248 | 4 | GO:0006971 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | ABL1 UBQLN4 KDM4E FANCC MET UBR5 SUPT6H KHDC3L NYNRIN NFRKB KCNK2 FGFR4 TAF4 HERC2 VCPIP1 RNF169 EP400 CCT7 TEP1 APLF E2F8 PBRM1 ARID2 MDC1 SMARCA2 ATF1 HDAC10 KDM1A IL7R | 4.57e-05 | 1081 | 248 | 29 | GO:0006259 |
| GeneOntologyBiologicalProcess | embryo development | NCOA6 SP3 ABL1 HIPK1 CDH23 BIRC6 ZEB2 MAPK8IP3 BAP1 HOXC6 SUPT6H KHDC3L NFRKB PRRC2B HNF1A ZEB1 VTN FN1 TCOF1 BRD3 REST E2F8 PPP4R4 TGFBR3 FOXP4 ARNT PBRM1 ARID2 TET1 LRP4 LRP5 UBR3 MACF1 HCFC1 KDM1A | 5.24e-05 | 1437 | 248 | 35 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | KDM4E MET KHDC3L NFRKB FGFR4 EP400 CCT7 APLF E2F8 PBRM1 ARID2 SMARCA2 ATF1 HDAC10 | 5.50e-05 | 333 | 248 | 14 | GO:0051054 |
| GeneOntologyBiologicalProcess | neuron projection development | ABL1 CDH23 ADGRV1 TRIP11 ZEB2 MAPK8IP3 SLC12A5 UNC5A MET HMCN2 KHDC3L FGFR3 ADGRF1 ALK FAT4 FN1 FAT3 APBB2 REST ARHGEF25 BTBD3 PBRM1 MEGF9 FARP1 TET1 LRP4 MACF1 ROBO2 ATF1 RAPGEF2 MYO16 KDM1A | 7.49e-05 | 1285 | 248 | 32 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 8.65e-05 | 150 | 248 | 9 | GO:0000018 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | VAPB NCOA6 ABL1 SREBF2 CDH23 LYST SLC12A5 MET SLC24A4 PTPRJ PKHD1 PLCB2 FGFR3 FGFR4 USF2 MED13 WNK2 PCSK9 SLC12A6 HNF1A HECTD4 GRM1 GRM5 SLC12A2 ANGPTL4 ABCB11 LRP5 HAMP MBD5 HCFC1 SLC26A6 | 1.04e-04 | 1249 | 248 | 31 | GO:0048878 |
| GeneOntologyBiologicalProcess | DNA repair | ABL1 UBQLN4 KDM4E FANCC UBR5 KHDC3L NYNRIN NFRKB TAF4 HERC2 VCPIP1 RNF169 EP400 APLF PBRM1 ARID2 MDC1 SMARCA2 HDAC10 KDM1A | 1.19e-04 | 648 | 248 | 20 | GO:0006281 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | DDAH1 ABL1 UBQLN4 TNFRSF10A KDM4E BDKRB2 MET KHDC3L NFRKB KCNK2 TAF4 PCBP4 RNF169 EP400 PBRM1 ARID2 SMARCA2 HDAC10 KDM1A | 1.22e-04 | 598 | 248 | 19 | GO:0080135 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SP3 MYLK HIPK1 ESR2 ASH1L CDH23 ITGA2 TRIP11 MAPK8IP3 FANCC MET SLC24A4 PKHD1 FGFR3 FGFR4 HNF1A FAT4 ZEB1 SFTPB FAT3 REST CRB1 TGFBR3 PBRM1 SLC12A2 MEGF9 ARID2 LRP4 LRP5 ROBO2 GAA | 1.38e-04 | 1269 | 248 | 31 | GO:0009887 |
| GeneOntologyBiologicalProcess | placenta development | 1.42e-04 | 197 | 248 | 10 | GO:0001890 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | SP3 ABL1 CDH23 RPS17 ADGRV1 TNFRSF10A ZEB2 BDKRB2 BAP1 FANCC ADRB2 SQSTM1 ALK RC3H2 HNF1A APBB2 CRB1 EPG5 TGFBR3 ARNT SLC12A2 SMARCA2 ATF1 HAMP KDM1A IL7R EMCN | 1.52e-04 | 1043 | 248 | 27 | GO:0048871 |
| GeneOntologyBiologicalProcess | DNA recombination | ABL1 UBQLN4 KDM4E SUPT6H KHDC3L NFRKB RNF169 EP400 TEP1 APLF ARID2 HDAC10 KDM1A IL7R | 1.58e-04 | 368 | 248 | 14 | GO:0006310 |
| GeneOntologyBiologicalProcess | neuron development | ABL1 CDH23 ADGRV1 TRIP11 ZEB2 MAPK8IP3 SLC12A5 UNC5A MET HMCN2 KHDC3L KCNQ3 FGFR3 ADGRF1 ALK FAT4 FN1 FAT3 APBB2 REST ARHGEF25 BTBD3 CRB1 PBRM1 MEGF9 FARP1 TET1 LRP4 MACF1 ROBO2 ATF1 RAPGEF2 MYO16 KDM1A | 1.67e-04 | 1463 | 248 | 34 | GO:0048666 |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | CDH23 ADGRV1 ZEB2 BDKRB2 BAP1 ADRB2 HNF1A APBB2 CRB1 EPG5 SLC12A2 ATF1 HAMP | 2.17e-04 | 334 | 248 | 13 | GO:0060249 |
| GeneOntologyBiologicalProcess | tissue homeostasis | CDH23 ADGRV1 ZEB2 BDKRB2 BAP1 ADRB2 HNF1A APBB2 CRB1 EPG5 SLC12A2 ATF1 HAMP | 2.17e-04 | 334 | 248 | 13 | GO:0001894 |
| GeneOntologyBiologicalProcess | chromatin remodeling | LIN54 ASH1L KDM4E BAP1 KMT2C UBR5 SUPT6H NFRKB HNF1A EP400 BRD3 REST APLF PBRM1 ARID2 TET1 SMARCA2 BICRAL HDAC10 HCFC1 KDM1A | 2.59e-04 | 741 | 248 | 21 | GO:0006338 |
| GeneOntologyCellularComponent | chromatin | SP3 SP4 POU6F2 ESR2 SREBF2 KDM4E ZEB2 FANCC TRIM66 HOXC6 UBR5 NFATC3 NFRKB NFYA NFYB TAF4 USF2 SAP130 HNF1A ZEB1 EP400 RBL2 BRD3 REST RFX1 CREM E2F8 ZNF711 FOXP4 ARNT PBRM1 ARID2 TET1 SMARCA2 GMEB1 BICRAL ATF1 HCFC1 KDM1A | 1.94e-06 | 1480 | 247 | 39 | GO:0000785 |
| GeneOntologyCellularComponent | apical part of cell | SLC17A2 CDH23 SLC52A3 ADRB2 SLC24A4 KCNK2 PKHD1 KISS1 SLC12A6 FAT4 FN1 PODXL LCT CRB1 SLC12A2 ABCB11 HAMP RAPGEF2 SLC26A6 PCM1 | 2.71e-05 | 592 | 247 | 20 | GO:0045177 |
| GeneOntologyCellularComponent | transcription regulator complex | NCOA6 SP3 LIN54 NFATC3 NFYA NFYB TAF4 HNF1A NRF1 RBL2 REST PAAF1 CREM E2F8 ARNT DACH2 ARID2 ATF1 SPEN KDM1A | 2.97e-05 | 596 | 247 | 20 | GO:0005667 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA6 RBM44 LIN54 UBQLN4 BAP1 NUP54 FANCC KMT2C SUPT6H NFRKB NFYA NFYB AGFG1 SAGE1 TAF4 SAP130 MED13 EP400 PAAF1 TEP1 CREM E2F8 PCF11 ARNT PBRM1 ARID2 TET1 SMARCA2 BICRAL ATF1 HDAC10 HCFC1 | 1.93e-04 | 1377 | 247 | 32 | GO:0140513 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC17A2 SLC52A3 ADRB2 SLC24A4 KCNK2 PKHD1 KISS1 SLC12A6 FN1 PODXL LCT CRB1 SLC12A2 ABCB11 RAPGEF2 SLC26A6 | 2.39e-04 | 487 | 247 | 16 | GO:0016324 |
| GeneOntologyCellularComponent | cell leading edge | PDE4A ABL1 MYLK PDLIM7 CADM4 ADGRV1 MAPK8IP3 SLC12A5 UNC5A PTPRJ PODXL APBB2 CDC42BPB TLN1 MACF1 ROBO2 | 3.20e-04 | 500 | 247 | 16 | GO:0031252 |
| GeneOntologyCellularComponent | SWI/SNF complex | 4.09e-04 | 30 | 247 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | non-motile cilium | 5.59e-04 | 196 | 247 | 9 | GO:0097730 | |
| GeneOntologyCellularComponent | cell body | ABL1 ESR2 CHRM4 MAPK8IP3 SLC12A5 UNC5A MET ADRB2 HMCN2 KCNK2 AGFG1 KCNQ3 KISS1 ALK PODXL CCT7 GRM1 SLC12A2 IGHMBP2 LRP4 WDFY3 RAPGEF2 HCFC1 | 6.92e-04 | 929 | 247 | 23 | GO:0044297 |
| GeneOntologyCellularComponent | ATF4-CREB1 transcription factor complex | 8.21e-04 | 4 | 247 | 2 | GO:1990589 | |
| GeneOntologyCellularComponent | leading edge membrane | 9.14e-04 | 210 | 247 | 9 | GO:0031256 | |
| GeneOntologyCellularComponent | axon | ABL1 ITGA2 CHRM4 MAPK8IP3 BLVRB ADRB2 HMCN2 KCNQ5 KCNK2 AP3M2 KCNQ3 ALK SLC12A6 APBB2 GRM1 AP3M1 IGHMBP2 ROBO2 WDFY3 PUM1 MDGA1 HCFC1 | 9.36e-04 | 891 | 247 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 9.78e-04 | 96 | 247 | 6 | GO:0070603 | |
| Domain | SLC12A_fam | 7.42e-05 | 7 | 244 | 3 | IPR004842 | |
| Domain | BROMODOMAIN_1 | 1.13e-04 | 37 | 244 | 5 | PS00633 | |
| Domain | SLC12_C | 1.18e-04 | 8 | 244 | 3 | IPR018491 | |
| Domain | SLC12 | 1.18e-04 | 8 | 244 | 3 | PF03522 | |
| Domain | Bromodomain | 1.29e-04 | 38 | 244 | 5 | PF00439 | |
| Domain | Metabotropic_Glu_rcpt_Homer-bd | 1.70e-04 | 2 | 244 | 2 | IPR019588 | |
| Domain | GluR_Homer-bdg | 1.70e-04 | 2 | 244 | 2 | PF10606 | |
| Domain | GPCR_3_mtglu_rcpt_1 | 1.70e-04 | 2 | 244 | 2 | IPR001256 | |
| Domain | GluR_Homer-bdg | 1.70e-04 | 2 | 244 | 2 | SM01229 | |
| Domain | GPCR_3_mtglu_rcpt_5 | 1.70e-04 | 2 | 244 | 2 | IPR000202 | |
| Domain | BROMODOMAIN_2 | 1.86e-04 | 41 | 244 | 5 | PS50014 | |
| Domain | Ig_I-set | 2.05e-04 | 190 | 244 | 10 | IPR013098 | |
| Domain | I-set | 2.05e-04 | 190 | 244 | 10 | PF07679 | |
| Domain | Bromodomain | 2.09e-04 | 42 | 244 | 5 | IPR001487 | |
| Domain | - | 2.09e-04 | 42 | 244 | 5 | 1.20.920.10 | |
| Domain | BROMO | 2.09e-04 | 42 | 244 | 5 | SM00297 | |
| Domain | CPH_domain | 5.06e-04 | 3 | 244 | 2 | IPR021097 | |
| Domain | KID | 5.06e-04 | 3 | 244 | 2 | PS50953 | |
| Domain | Coactivator_CBP_pKID | 5.06e-04 | 3 | 244 | 2 | IPR003102 | |
| Domain | Cul7 | 5.06e-04 | 3 | 244 | 2 | PF11515 | |
| Domain | pKID | 5.06e-04 | 3 | 244 | 2 | PF02173 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 3.57e-05 | 29 | 187 | 5 | M48076 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 4.46e-05 | 6 | 187 | 3 | M22047 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 4.46e-05 | 6 | 187 | 3 | MM1564 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 7.73e-05 | 7 | 187 | 3 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 7.73e-05 | 7 | 187 | 3 | MM15081 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 SP3 SP4 PDLIM7 TSC22D2 SH3BP4 SQSTM1 AGFG1 SAP130 WNK2 RIC1 USP53 PRUNE2 EP400 TCOF1 MLLT10 GRM1 CCDC141 PKNOX2 SLC12A2 ARID2 TLN1 MDC1 AKAP13 SPEN | 1.43e-15 | 430 | 251 | 25 | 35044719 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZXDC NCOA6 PDE4A ABL1 CUL9 ANKHD1 BIRC6 LYST CHRM4 MAPK8IP3 BAP1 SH3BP4 SLC52A3 KMT2C TP53I13 HERC2 ARHGAP21 MED13 WNK2 RIC1 PRRC2B EP400 NRF1 AGPAT2 HECTD4 MLLT10 TEP1 CDC42BPB TLN1 LRP4 LRP5 AKAP13 WDFY3 MAPKBP1 MBD5 PUM1 SPEN HCFC1 | 1.52e-15 | 1105 | 251 | 38 | 35748872 |
| Pubmed | IL16 ASH1L TNRC6B CUL9 ANKHD1 TRIM66 HMCN2 UBR5 SQSTM1 NFRKB TAF4 SAP130 PRRC2B EP400 TTC28 TCOF1 FAT3 PKP4 AOX1 RNF213 YTHDC2 BRD3 TEP1 ZNF711 FOXP4 PBRM1 ARID2 SMARCA2 LRP4 MACF1 BICRAL WDFY3 RAPGEF2 TOPORS KDM1A PCM1 ZNF646 | 1.16e-14 | 1116 | 251 | 37 | 31753913 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | POU6F2 ASH1L SREBF2 TNRC6B ADGRV1 DNAH14 MAPK8IP3 SH3BP4 TMCO4 KMT2C CFAP20DC TSC22D1 KCNQ5 PTPRJ SUPT6H TAF4 SAP130 WNK2 GOLGB1 RIC1 USP53 PRUNE2 SLC12A6 MAN2B2 NRF1 HECTD4 APBB2 RNF213 TEP1 CDC42BPB PPP4R4 PKNOX2 FOXP4 FARP1 SMARCA2 LRP5 MACF1 AKAP13 QSER1 RAPGEF2 MBD5 PCM1 | 3.73e-14 | 1489 | 251 | 42 | 28611215 |
| Pubmed | NCOA6 LIN54 TNRC6B CUL9 RPS17 ANKHD1 ZEB2 BAP1 SCAF4 NUP54 KMT2C NFATC3 SQSTM1 NFRKB NFYA NFYB TAF4 HERC2 SAP130 PRRC2B HNF1A ZEB1 EP400 CCT7 MLLT10 RFX1 PCF11 FOXP4 ARNT PBRM1 ARID2 MDC1 SMARCA2 GMEB1 ATF1 QSER1 PUM1 SPEN HCFC1 KDM1A PCM1 | 4.49e-14 | 1429 | 251 | 41 | 35140242 | |
| Pubmed | CADM4 LIN54 TNRC6B BIRC6 TRIP11 SH3BP4 MET UBR5 SQSTM1 ARHGAP21 GOLGB1 PRRC2B FAT4 FN1 EP400 TTC28 TCOF1 PODXL APBB2 RNF213 CCT7 NCAPH CDC42BPB BTBD3 CRB1 PCF11 SLC12A2 RAPGEF2 SPEN PCM1 | 9.92e-14 | 777 | 251 | 30 | 35844135 | |
| Pubmed | NCOA6 PDLIM7 TNRC6B ANKHD1 SCAF4 KMT2C NFRKB TAF4 SAP130 PRRC2B VCPIP1 EP400 TTC28 TCOF1 NCAPH RFX1 ARID2 TLN1 MDC1 TET1 QSER1 SPEN HCFC1 KDM1A PCM1 | 3.54e-13 | 549 | 251 | 25 | 38280479 | |
| Pubmed | HIPK1 SREBF2 FAM13B NUP54 SH3BP4 KMT2C TSC22D1 NFYA NFYB AGFG1 HERC2 USF2 WNK2 GOLGB1 USP53 CDC42BPB KRT23 ARID2 MACF1 AKAP13 BICRAL RAPGEF2 MBD5 | 1.48e-12 | 486 | 251 | 23 | 20936779 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA6 LIN54 ZEB2 NUP54 KMT2C NFRKB TAF4 PRRC2B ZEB1 EP400 FOXP4 ARNT PBRM1 ARID2 MDC1 TET1 SMARCA2 QSER1 SPEN KDM1A | 1.58e-12 | 351 | 251 | 20 | 38297188 |
| Pubmed | PDE4A TNRC6B ARMCX4 TRIP11 ZEB2 MAPK8IP3 SLC12A5 UBR5 NFATC3 TAF4 HERC2 ARHGAP21 WNK2 GOLGB1 PRRC2B ZEB1 TCOF1 PKP4 HECTD4 GRM1 GRM5 CDC42BPB PBRM1 FARP1 MACF1 WDFY3 QSER1 RAPGEF2 KDM1A PCM1 | 2.15e-11 | 963 | 251 | 30 | 28671696 | |
| Pubmed | SP3 PDLIM7 TNRC6B RPS17 ANKHD1 SCAF4 BLVRB KMT2C SUPT6H SQSTM1 NFRKB TAF4 HERC2 MED13 GOLGB1 RNF169 EP400 PKP4 AGPAT2 CCT7 YTHDC2 BRD3 CDC42BPB PCF11 PBRM1 SLC12A2 FARP1 ARID2 IGHMBP2 TLN1 MDC1 RCL1 SMARCA2 MACF1 ATF1 SPEN KDM1A | 6.68e-11 | 1497 | 251 | 37 | 31527615 | |
| Pubmed | NCOA6 SP4 LIN54 ZEB2 SCAF4 KMT2C UBR5 NFRKB TAF4 USF2 SAP130 PRRC2B EP400 CCT7 RFX1 E2F8 PCF11 ARNT ARID2 TLN1 SMARCA2 GMEB1 BICRAL ATF1 QSER1 SPEN DCXR HCFC1 KDM1A PCM1 GABPB1 | 1.26e-10 | 1103 | 251 | 31 | 34189442 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SP3 SP4 POU6F2 ESR2 ASH1L SREBF2 TSC22D2 ZEB2 TSC22D1 HOXC6 NFATC3 NFYA NFYB USF2 RC3H2 HNF1A ZEB1 REST RFX1 CREM E2F8 ZNF711 PKNOX2 FOXP4 ARNT DACH2 GMEB1 ATF1 | 1.33e-10 | 908 | 251 | 28 | 19274049 |
| Pubmed | NCOA6 LIN54 BAP1 NFRKB SAP130 MED13 PRRC2B EP400 PCF11 FOXP4 PBRM1 MDC1 SMARCA2 QSER1 HCFC1 KDM1A | 1.43e-10 | 268 | 251 | 16 | 33640491 | |
| Pubmed | HIPK1 TNRC6B CUL9 ZEB2 SLC12A5 UNC5A UBR5 ARHGAP21 PRRC2B VCPIP1 EP400 TTC28 EPG5 MEGF9 TLN1 MACF1 MAPKBP1 PUM1 SPEN | 1.76e-10 | 407 | 251 | 19 | 12693553 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | HIPK1 LIN54 CUL9 ANKHD1 ZEB2 BAP1 UBR5 AGL NFYA USF2 SAP130 KIF27 EP400 NRF1 RBL2 NCAPH RFX1 CREM FOXP4 ARNT ATF1 QSER1 PUM1 SPEN HCFC1 GAA KDM1A | 1.82e-10 | 857 | 251 | 27 | 25609649 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIPK1 LIN54 CUL9 TRIP11 UBR5 NFATC3 SUPT6H SQSTM1 AGFG1 GOLGB1 PRRC2B VCPIP1 EP400 TTC28 TCOF1 ARNT ARID2 MACF1 TOPORS SPEN KDM1A PCM1 | 4.15e-10 | 588 | 251 | 22 | 38580884 |
| Pubmed | LIN54 UBQLN4 TNRC6B ANKHD1 BIRC6 ZEB2 BAP1 UBR5 SQSTM1 ARHGAP21 GOLGB1 VCPIP1 ZEB1 TTC28 RFX1 TET1 KDM1A PCM1 | 1.93e-09 | 418 | 251 | 18 | 34709266 | |
| Pubmed | NCOA6 PDLIM7 HIPK1 UBQLN4 ASH1L ZEB2 UBR5 HERC2 SAP130 GOLGB1 VCPIP1 FN1 RFX1 EPG5 ARNT PBRM1 GMEB1 LRP5 MACF1 PUM1 TOPORS | 2.62e-09 | 591 | 251 | 21 | 15231748 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | EHD4 SAP130 PRRC2B TCOF1 CCT7 BRD3 MLLT10 PBRM1 MDC1 TET1 SMARCA2 HCFC1 KDM1A | 3.38e-09 | 203 | 251 | 13 | 22083510 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VAPB NCOA6 LIN54 UBQLN4 RPS17 BAP1 SCAF4 KMT2C SUPT6H NFRKB TAF4 USF2 SAP130 VCPIP1 RNF169 EP400 TCOF1 AGPAT2 BRD3 REST CREM ARNT PBRM1 MDC1 ATF1 SUMO3 QSER1 SPEN HCFC1 KDM1A C1orf174 | 5.67e-09 | 1294 | 251 | 31 | 30804502 |
| Pubmed | NCOA6 TNRC6B ADGRV1 BIRC6 BAP1 KMT2C UBR5 PRUNE2 TTC28 CDC42BPB TLN1 MACF1 WDFY3 | 1.17e-08 | 225 | 251 | 13 | 12168954 | |
| Pubmed | CUL9 ANKHD1 BIRC6 UBR5 SUPT6H HERC2 PRRC2B FN1 TCOF1 YTHDC2 PBRM1 TLN1 MDC1 RCL1 SMARCA2 MACF1 PUM1 SPEN HCFC1 KDM1A PCM1 | 1.49e-08 | 653 | 251 | 21 | 22586326 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 ABL1 TRIP11 LYST SH3BP4 KCNQ5 NFATC3 SQSTM1 AGFG1 ARHGAP21 BICC1 GOLGB1 VCPIP1 USP53 TTC28 E2F8 PPP4R4 SLC12A2 TET1 MACF1 AKAP13 RAPGEF2 PUM1 PCM1 | 2.07e-08 | 861 | 251 | 24 | 36931259 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | LIN54 ZEB2 BAP1 NFRKB TAF4 HERC2 RNF169 BRD3 RFX1 ZNF711 PBRM1 SBNO1 ARID2 MDC1 RCL1 SUMO3 QSER1 SPEN HCFC1 KDM1A | 2.29e-08 | 608 | 251 | 20 | 36089195 |
| Pubmed | ZXDC SP3 SP4 ESR2 ASH1L TSC22D1 NFYA NFYB USF2 HNF1A ZEB1 BRD3 REST MLLT10 RFX1 CREM ARNT PBRM1 ARID2 SMARCA2 GMEB1 ATF1 ZNF646 | 2.83e-08 | 808 | 251 | 23 | 20412781 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 LIN54 RPS17 SCAF4 NFRKB AGFG1 TAF4 SAP130 ALK RNF169 EP400 RFX1 CREM ZNF711 PCF11 ARID2 MDC1 RCL1 ATF1 QSER1 PUM1 SPEN HCFC1 PCM1 C1orf174 | 3.43e-08 | 954 | 251 | 25 | 36373674 |
| Pubmed | 4.00e-08 | 130 | 251 | 10 | 12421765 | ||
| Pubmed | ZXDC SP3 SREBF2 BIRC6 MET KMT2C SQSTM1 USF2 HNF1A BRD3 REST MLLT10 CREM PKNOX2 FOXP4 ARNT PBRM1 IGHMBP2 SMARCA2 GMEB1 MACF1 | 6.00e-08 | 709 | 251 | 21 | 22988430 | |
| Pubmed | HIPK1 UBQLN4 ASH1L CUL9 ARMCX4 TRIP11 ZEB2 MAPK8IP3 TRIM66 HERC2 ARHGAP21 MED13 VCPIP1 FN1 TTC28 TCOF1 RBL2 HECTD4 APBB2 CCT7 CDC42BPB MEGF9 SBNO1 LRP4 MACF1 SUMO3 WDFY3 RAPGEF2 PCM1 | 6.60e-08 | 1285 | 251 | 29 | 35914814 | |
| Pubmed | NCOA6 ADGRV1 ANKHD1 BAP1 KMT2C SUPT6H MED13 WNK2 USP53 EP400 HECTD4 NCAPH MDC1 TET1 LRP4 ROBO2 KDM1A ZNF646 | 7.14e-08 | 529 | 251 | 18 | 14621295 | |
| Pubmed | VAPB TNRC6B ANKHD1 SCAF4 BLVRB CEP78 TCHHL1 SQSTM1 AGL HERC2 ALK PRRC2B RC3H2 VTN FN1 EP400 TCOF1 RBM45 AP3M1 CDC42BPB UFM1 PCF11 PBRM1 FARP1 TLN1 RCL1 SUMO3 HCFC1 PCM1 C1orf174 | 7.52e-08 | 1371 | 251 | 30 | 36244648 | |
| Pubmed | BIRC6 SCAF4 TRIM66 TSC22D1 RIC1 SEC14L1 PRUNE2 RNF169 MAN2B2 RNF213 CDC42BPB PPP4R4 PCF11 ARID2 UBR3 MACF1 MBD5 | 1.38e-07 | 493 | 251 | 17 | 15368895 | |
| Pubmed | 1.79e-07 | 116 | 251 | 9 | 30804394 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 MAPK8IP3 BAP1 SCAF4 NFRKB MED13 VCPIP1 RNF169 ZEB1 EP400 TCOF1 YTHDC2 BRD3 REST RFX1 PCF11 MDC1 SMARCA2 TOPORS SPEN PCM1 | 2.57e-07 | 774 | 251 | 21 | 15302935 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA6 TNRC6B ANKHD1 TRIP11 NUP54 KMT2C SAP130 BICC1 GOLGB1 PRRC2B AP3M1 PCF11 ARNT SMARCA2 QSER1 PUM1 | 2.65e-07 | 457 | 251 | 16 | 32344865 |
| Pubmed | VAPB TNRC6B BIRC6 SQSTM1 NFRKB AGFG1 VCPIP1 RNF169 EP400 TTC28 RNF213 SLC12A2 SLC20A1 MDC1 AKAP13 QSER1 PUM1 HCFC1 SLC26A6 PCM1 | 4.58e-07 | 733 | 251 | 20 | 34672954 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | POU6F2 ESR2 ASH1L SREBF2 ZKSCAN7 TRIM22 ZEB2 HOXC6 NFATC3 NFYA HNF1A RBL2 REST MLLT10 E2F8 PKNOX2 ARNT DACH2 GMEB1 HDAC10 SPEN HCFC1 | 4.94e-07 | 877 | 251 | 22 | 20211142 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDLIM7 SCAF4 NUP54 EHD4 UBR5 SUPT6H SQSTM1 HERC2 GOLGB1 VTN EP400 TCOF1 CCT7 YTHDC2 PBRM1 SLC12A2 SLC20A1 TLN1 MDC1 MACF1 PUM1 SPEN KDM1A PCM1 | 4.95e-07 | 1024 | 251 | 24 | 24711643 |
| Pubmed | PDLIM7 UBQLN4 TNRC6B ANKHD1 TRIP11 PMEPA1 TRIM22 NYNRIN PCBP4 WNK2 PRRC2B FAT4 TEP1 ROBO2 MAPKBP1 PUM1 SPEN GABPB1 | 5.48e-07 | 608 | 251 | 18 | 16713569 | |
| Pubmed | PDLIM7 TNRC6B TRIP11 SQSTM1 ARHGAP21 GOLGB1 PRRC2B VCPIP1 TTC28 YTHDC2 SLC12A2 MACF1 | 5.51e-07 | 263 | 251 | 12 | 34702444 | |
| Pubmed | 6.40e-07 | 99 | 251 | 8 | 19730683 | ||
| Pubmed | Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. | 8.56e-07 | 45 | 251 | 6 | 27337956 | |
| Pubmed | VAPB BIRC6 KMT2C TAF4 USF2 RNF169 REST SBNO1 TET1 MACF1 AKAP13 PUM1 KDM1A | 1.15e-06 | 335 | 251 | 13 | 15741177 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.26e-06 | 146 | 251 | 9 | 23892456 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ZEB2 KMT2C NFRKB RC3H2 ZEB1 EP400 RBL2 BRD3 FOXP4 PBRM1 ARID2 SMARCA2 BICRAL DCXR | 1.42e-06 | 398 | 251 | 14 | 35016035 |
| Pubmed | SP3 SREBF2 TSC22D2 BIRC6 BAP1 KMT2C UBR5 NFRKB KCNK2 NFYB TAF4 USF2 MED13 RBL2 REST CREM PPP4R4 ARNT PBRM1 DACH2 SBNO1 SLC20A1 ARID2 NXPH3 SLC26A6 PCM1 GABPB1 | 1.42e-06 | 1327 | 251 | 27 | 32694731 | |
| Pubmed | 1.48e-06 | 4 | 251 | 3 | 15717924 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DDAH1 ADGRV1 EHD4 SH3BP4 BLVRB PTPRJ SQSTM1 PKHD1 ALK FN1 NRF1 PODXL RBL2 AOX1 CDC42BPB TGFBR3 TLN1 ABCB11 ROBO2 MBD5 SPEN DCXR GAA | 1.56e-06 | 1016 | 251 | 23 | 19056867 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | VAPB SREBF2 TNRC6B PMEPA1 SCAF4 SH3BP4 NFYB MED13 PKP4 REST ARID2 TET1 RCL1 WDFY3 MBD5 PUM1 | 2.13e-06 | 536 | 251 | 16 | 15840001 |
| Pubmed | VAPB SREBF2 TNRC6B PMEPA1 SCAF4 SH3BP4 NFYB MED13 PKP4 REST ARID2 TET1 RCL1 WDFY3 MBD5 PUM1 | 2.24e-06 | 538 | 251 | 16 | 10512203 | |
| Pubmed | 2.44e-06 | 83 | 251 | 7 | 28794006 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | KMT2C PKHD1 GOLGB1 VCPIP1 RNF213 CCT7 YTHDC2 AP3M1 TLN1 SPEN | 3.08e-06 | 208 | 251 | 10 | 33230847 |
| Pubmed | TNRC6B UBR5 SQSTM1 ARHGAP21 VCPIP1 RC3H2 TTC28 YTHDC2 MACF1 PCM1 | 3.22e-06 | 209 | 251 | 10 | 36779422 | |
| Pubmed | ACAP1 IL16 TNFRSF10A BIRC6 AGL PRUNE2 MAN2B2 TCOF1 RBL2 AOX1 TEP1 IL7R | 3.38e-06 | 313 | 251 | 12 | 20800603 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 3.82e-06 | 167 | 251 | 9 | 20362541 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | UBR5 SUPT6H HERC2 EP400 TCOF1 HECTD4 CCT7 YTHDC2 PCF11 PBRM1 ARID2 MDC1 SMARCA2 KDM1A | 4.52e-06 | 440 | 251 | 14 | 34244565 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | VAPB TNRC6B ANKHD1 TRIP11 SCAF4 AGFG1 ARHGAP21 GOLGB1 PRRC2B VCPIP1 DSC1 EP400 TCOF1 CCT7 YTHDC2 NCAPH ARID2 TLN1 MACF1 HCFC1 PCM1 | 5.00e-06 | 934 | 251 | 21 | 33916271 |
| Pubmed | VAPB IL16 DDAH1 RPS17 ITGA2 TRIP11 MAPK8IP3 SLC12A5 KCNQ3 PLPPR2 ARHGAP21 WNK2 PRRC2B SLC12A6 FN1 PKP4 CCT7 YTHDC2 GRM1 GRM5 AP3M1 CDC42BPB FARP1 TLN1 MACF1 RAPGEF2 PCM1 | 5.74e-06 | 1431 | 251 | 27 | 37142655 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 6.27e-06 | 134 | 251 | 8 | 25452129 | |
| Pubmed | VAPB TRIM22 FANCC UBR5 SAGE1 SAP130 MED13 RNF169 ZEB1 EP400 RBM45 RFX1 MDC1 TOPORS | 6.30e-06 | 453 | 251 | 14 | 29656893 | |
| Pubmed | 7.31e-06 | 6 | 251 | 3 | 25636086 | ||
| Pubmed | 7.31e-06 | 6 | 251 | 3 | 28647557 | ||
| Pubmed | CUL9 ZEB2 UBR5 SAP130 EP400 RFX1 FOXP4 SMARCA2 MACF1 QSER1 SPEN | 7.36e-06 | 282 | 251 | 11 | 23667531 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 8.40e-06 | 184 | 251 | 9 | 32908313 | |
| Pubmed | BIRC6 ZEB2 KMT2C SUPT6H RC3H2 EP400 TTC28 BRD3 REST NCAPH CCDC141 PBRM1 SPEN HCFC1 | 9.31e-06 | 469 | 251 | 14 | 27634302 | |
| Pubmed | 1.27e-05 | 7 | 251 | 3 | 16772167 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 1.29e-05 | 71 | 251 | 6 | 28319113 | |
| Pubmed | ANKHD1 TRIP11 SCAF4 BLVRB MET GOLGB1 VTN TCOF1 CDC42BPB TLN1 MACF1 ATF1 | 1.38e-05 | 360 | 251 | 12 | 33111431 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.43e-05 | 150 | 251 | 8 | 28242625 | |
| Pubmed | 1.44e-05 | 21 | 251 | 4 | 15452121 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | VAPB BAP1 UBR5 SUPT6H SQSTM1 NFRKB HERC2 PRRC2B VCPIP1 USP53 DSC1 TTC28 TCOF1 RBM45 CCT7 YTHDC2 PAAF1 AP3M1 SMARCA2 DCXR HCFC1 | 1.50e-05 | 1005 | 251 | 21 | 19615732 |
| Pubmed | UBR5 SUPT6H TAF4 SAP130 MED13 RNF169 EP400 RNF213 CCT7 BRD3 NCAPH UFM1 PBRM1 SBNO1 MDC1 SMARCA2 ATF1 SUMO3 QSER1 HCFC1 KDM1A | 1.72e-05 | 1014 | 251 | 21 | 32416067 | |
| Pubmed | CUL9 TRIP11 SCAF4 FANCC UBR5 SQSTM1 ARHGAP21 DSC1 TTC28 TCOF1 PKP4 ARID2 TLN1 SMARCA2 MACF1 PCM1 | 1.74e-05 | 634 | 251 | 16 | 34591612 | |
| Pubmed | 1.77e-05 | 75 | 251 | 6 | 25593309 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SCAF4 KMT2C TAF4 ARHGAP21 RIC1 FN1 YTHDC2 BRD3 AP3M1 ARID2 IGHMBP2 PUM1 HCFC1 KDM1A | 1.77e-05 | 497 | 251 | 14 | 36774506 |
| Pubmed | UBL7 BIRC6 TRIP11 SUPT6H AGL ARHGAP21 MED13 SLC12A6 FN1 CCDC141 CDC42BPB ZNF711 TLN1 MACF1 | 1.77e-05 | 497 | 251 | 14 | 23414517 | |
| Pubmed | NCOA6 TRIP11 NFYB PRRC2B FAT4 VTN TTC28 RFX1 IFI35 AP3M1 PPP4R4 PBRM1 ARID2 SMARCA2 WDFY3 SPEN | 1.87e-05 | 638 | 251 | 16 | 31182584 | |
| Pubmed | VAPB MYLK TTC16 LIN54 ASH1L RPS17 LYST ZEB2 NUP54 EHD4 TCHHL1 PKHD1 TAF4 ARHGAP21 MED13 GOLGB1 PRRC2B SLC12A6 BRD3 NCAPH PPP4R4 KRT23 PCF11 SBNO1 MACF1 SPEN | 1.89e-05 | 1442 | 251 | 26 | 35575683 | |
| Pubmed | 1.99e-05 | 157 | 251 | 8 | 30186101 | ||
| Pubmed | 2.03e-05 | 8 | 251 | 3 | 11395011 | ||
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 2.03e-05 | 8 | 251 | 3 | 21613606 | |
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 2.11e-05 | 23 | 251 | 4 | 23152823 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | VAPB DDAH1 BIRC6 TMCO4 UBR5 AGFG1 HERC2 ARHGAP21 PODXL PKP4 IFI35 CDC42BPB PBRM1 SLC12A2 LRP4 MACF1 DCXR | 2.17e-05 | 719 | 251 | 17 | 35337019 |
| Pubmed | SREBF2 ANKHD1 SH3BP4 CEP78 ARHGAP21 RIC1 PRRC2B RC3H2 VTN TTC28 PKP4 YTHDC2 ARNT AKAP13 QSER1 HCFC1 | 2.35e-05 | 650 | 251 | 16 | 38777146 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | PDLIM7 TNRC6B RPS17 ANKHD1 CEP78 SQSTM1 AGFG1 PRRC2B RC3H2 YTHDC2 CDC42BPB FARP1 TLN1 MACF1 AKAP13 PUM1 SPEN | 2.37e-05 | 724 | 251 | 17 | 36232890 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | LIN54 TNRC6B TRIM22 NFRKB TAF4 RNF169 EP400 ARNT DACH2 SBNO1 TLN1 SUMO3 HCFC1 | 2.38e-05 | 444 | 251 | 13 | 34795231 |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 2.50e-05 | 211 | 251 | 9 | 24097068 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | LIN54 RPS17 NFATC3 TAF4 USF2 SAP130 EP400 YTHDC2 RFX1 ARNT FARP1 ATF1 HCFC1 KDM1A ZNF646 | 2.55e-05 | 583 | 251 | 15 | 29844126 |
| Pubmed | 2.64e-05 | 119 | 251 | 7 | 23508102 | ||
| Pubmed | 2.79e-05 | 214 | 251 | 9 | 22199357 | ||
| Pubmed | 3.02e-05 | 9 | 251 | 3 | 19323993 | ||
| Pubmed | VAPB TNRC6B BIRC6 MAPK8IP3 MET KCNQ5 SQSTM1 KCNQ3 PLPPR2 WNK2 VCPIP1 CCT7 GRM5 AP3M1 CDC42BPB UFM1 MECR FARP1 IGHMBP2 UBR3 MACF1 PCM1 | 3.10e-05 | 1139 | 251 | 22 | 36417873 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ASH1L CEP78 NFRKB NFYB TAF4 HERC2 VTN BRD3 MLLT10 ZNF711 PBRM1 MDC1 SMARCA2 C1orf174 | 3.80e-05 | 533 | 251 | 14 | 30554943 |
| Pubmed | TRIP11 UBR5 SUPT6H ARHGAP21 GOLGB1 RC3H2 FAT4 DSC1 EP400 TCOF1 PODXL CCT7 NCAPH MDC1 RCL1 PUM1 KDM1A | 3.93e-05 | 754 | 251 | 17 | 35906200 | |
| Pubmed | LIN54 RPS17 SCAF4 NFRKB SAP130 RNF169 EP400 SBNO1 SPEN HCFC1 KDM1A | 4.03e-05 | 339 | 251 | 11 | 30415952 | |
| Pubmed | 4.08e-05 | 27 | 251 | 4 | 29374058 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 EHD4 SAP130 EP400 TCOF1 RNF213 RFX1 SBNO1 MDC1 SPEN HCFC1 | 4.25e-05 | 341 | 251 | 11 | 32971831 |
| Pubmed | 4.29e-05 | 10 | 251 | 3 | 17329413 | ||
| Pubmed | CADM4 SSTR3 SLC12A5 PTPRJ AP3M2 KCNQ3 ARHGAP21 GRM1 GRM5 SLC12A2 SLC20A1 ROBO2 | 4.36e-05 | 405 | 251 | 12 | 38187761 | |
| Interaction | HNF1B interactions | POU6F2 LIN54 ZEB2 BAP1 KMT2C NFRKB SAP130 PRRC2B HNF1A ZEB1 EP400 TCOF1 MLLT10 PBRM1 ARID2 SMARCA2 ATF1 QSER1 | 1.99e-11 | 190 | 245 | 18 | int:HNF1B |
| Interaction | FEV interactions | NCOA6 LIN54 ZEB2 BAP1 KMT2C NFRKB TAF4 PRRC2B ZEB1 EP400 MLLT10 RFX1 FOXP4 ARNT PBRM1 ARID2 ATF1 QSER1 | 6.02e-11 | 203 | 245 | 18 | int:FEV |
| Interaction | NFYC interactions | SP4 POU6F2 ESR2 LIN54 SREBF2 BAP1 NUP54 NFRKB NFYA NFYB TAF4 EP400 PON3 PBRM1 ARID2 BICRAL | 5.41e-10 | 177 | 245 | 16 | int:NFYC |
| Interaction | HNF4A interactions | NCOA6 LIN54 SREBF2 ZEB2 BAP1 KMT2C NFRKB TAF4 SAP130 HNF1A EP400 ARNT PBRM1 MECR ARID2 SMARCA2 QSER1 SPEN KDM1A | 1.25e-09 | 275 | 245 | 19 | int:HNF4A |
| Interaction | NFIX interactions | ESR2 LIN54 ZEB2 BAP1 KMT2C SQSTM1 NFRKB TAF4 SAP130 ZEB1 EP400 RFX1 PBRM1 ARID2 SMARCA2 QSER1 SPEN | 2.83e-09 | 227 | 245 | 17 | int:NFIX |
| Interaction | TNRC6A interactions | NCOA6 ESR2 TNRC6B TRIP11 TRIM66 KMT2C UBR5 SQSTM1 NYNRIN MED13 PRRC2B USP53 RC3H2 PCF11 MDC1 PUM1 KDM1A | 6.37e-08 | 280 | 245 | 17 | int:TNRC6A |
| Interaction | HDAC1 interactions | SP3 ESR2 UBQLN4 TNRC6B ANKHD1 BIRC6 ZEB2 BAP1 NUP54 UBR5 SQSTM1 NFYA NFYB SAP130 ARHGAP21 GOLGB1 VCPIP1 ZEB1 FN1 EP400 TTC28 RBL2 CCT7 REST PAAF1 NCAPH RFX1 CREM ARNT TLN1 TET1 SMARCA2 SPEN HCFC1 KDM1A PCM1 | 6.98e-08 | 1108 | 245 | 36 | int:HDAC1 |
| Interaction | KLF5 interactions | NCOA6 ESR2 RPS17 BAP1 KMT2C PRRC2B EP400 MLLT10 FOXP4 PBRM1 ARID2 SMARCA2 QSER1 HCFC1 | 1.24e-07 | 195 | 245 | 14 | int:KLF5 |
| Interaction | SP7 interactions | NCOA6 LIN54 ZEB2 SCAF4 KMT2C SAP130 PRRC2B EP400 RFX1 PCF11 FOXP4 ARNT PBRM1 ARID2 SMARCA2 QSER1 KDM1A | 2.07e-07 | 304 | 245 | 17 | int:SP7 |
| Interaction | RBBP7 interactions | ESR2 ASH1L SREBF2 ANKHD1 BIRC6 ZEB2 BAP1 SAP130 DSC1 EP400 TTC28 TCOF1 RBM45 CCT7 REST NCAPH TET1 SMARCA2 TOPORS SPEN HCFC1 KDM1A | 2.83e-07 | 507 | 245 | 22 | int:RBBP7 |
| Interaction | ELF1 interactions | LIN54 BAP1 NFRKB NFYA NFYB TAF4 EP400 PBRM1 ARID2 SMARCA2 ATF1 | 4.07e-07 | 126 | 245 | 11 | int:ELF1 |
| Interaction | TOP3B interactions | ZXDC NCOA6 PDE4A ABL1 TNRC6B CUL9 ANKHD1 BIRC6 LYST CHRM4 MAPK8IP3 BAP1 SH3BP4 SLC52A3 KMT2C TP53I13 HERC2 ARHGAP21 MED13 WNK2 RIC1 PRRC2B RC3H2 EP400 NRF1 AGPAT2 HECTD4 MLLT10 TEP1 CDC42BPB TLN1 MDC1 LRP4 LRP5 AKAP13 WDFY3 MAPKBP1 MBD5 PUM1 SPEN HCFC1 | 4.81e-07 | 1470 | 245 | 41 | int:TOP3B |
| Interaction | CRX interactions | SP3 SP4 IGFN1 ZEB2 KMT2C NFRKB PRRC2B EP400 FOXP4 ARNT PBRM1 ARID2 SMARCA2 QSER1 SPEN | 5.50e-07 | 254 | 245 | 15 | int:CRX |
| Interaction | KLF3 interactions | LIN54 ZEB2 SQSTM1 NFRKB TAF4 SAP130 ZEB1 EP400 FOXP4 PBRM1 ARID2 SMARCA2 QSER1 KDM1A | 8.31e-07 | 228 | 245 | 14 | int:KLF3 |
| Interaction | CREBBP interactions | NCOA6 SP3 HIPK1 ESR2 SREBF2 BAP1 SUPT6H NFYA NFYB KISS1 HNF1A ZEB1 RBL2 CREM EPG5 ARNT MDC1 SMARCA2 GMEB1 ATF1 HDAC10 TOPORS GAA | 1.26e-06 | 599 | 245 | 23 | int:CREBBP |
| Interaction | EGR2 interactions | NCOA6 ZEB2 KMT2C NFRKB PRRC2B EP400 FOXP4 ARID2 TET1 SMARCA2 QSER1 HCFC1 | 1.27e-06 | 171 | 245 | 12 | int:EGR2 |
| Interaction | CBX3 interactions | ESR2 LIN54 BAP1 TRIM66 NFRKB TAF4 SAP130 PRRC2B HNF1A RNF169 ZEB1 FN1 EP400 TCOF1 BRD3 REST RFX1 SBNO1 ARID2 MDC1 MACF1 SPEN KDM1A ZNF646 | 1.30e-06 | 646 | 245 | 24 | int:CBX3 |
| Interaction | CAMKV interactions | 1.81e-06 | 118 | 245 | 10 | int:CAMKV | |
| Interaction | KLF15 interactions | LIN54 RPS17 KMT2C SQSTM1 NFRKB TAF4 SAP130 PRRC2B EP400 NRF1 FOXP4 PBRM1 ARID2 GMEB1 QSER1 | 2.88e-06 | 290 | 245 | 15 | int:KLF15 |
| Interaction | CEBPA interactions | NCOA6 SP4 LIN54 ZEB2 SCAF4 KMT2C UBR5 NFRKB NFYA TAF4 USF2 SAP130 PRRC2B HNF1A EP400 CCT7 RFX1 E2F8 PCF11 ARNT ARID2 TLN1 SMARCA2 GMEB1 MACF1 BICRAL ATF1 SUMO3 QSER1 SPEN DCXR HCFC1 KDM1A PCM1 GABPB1 | 3.12e-06 | 1245 | 245 | 35 | int:CEBPA |
| Interaction | TERF2IP interactions | NCOA6 ESR2 LIN54 BAP1 SUPT6H NFRKB TAF4 SAP130 ZEB1 EP400 RFX1 PCF11 ARNT SBNO1 MDC1 WDFY3 QSER1 SPEN HCFC1 KDM1A C1orf174 | 4.28e-06 | 552 | 245 | 21 | int:TERF2IP |
| Interaction | WWTR1 interactions | NCOA6 IL16 PDLIM7 TNRC6B ANKHD1 PRRC2B VCPIP1 ZEB1 EP400 TTC28 NCAPH ARNT ARID2 TLN1 SUMO3 QSER1 HCFC1 PCM1 | 4.50e-06 | 422 | 245 | 18 | int:WWTR1 |
| Interaction | GATA2 interactions | NCOA6 ZEB2 BAP1 KMT2C SAP130 PRRC2B ZEB1 PBRM1 ARID2 SMARCA2 QSER1 KDM1A | 6.16e-06 | 199 | 245 | 12 | int:GATA2 |
| Interaction | KDM1B interactions | 6.39e-06 | 58 | 245 | 7 | int:KDM1B | |
| Interaction | FOS interactions | NCOA6 ABL1 ANKHD1 KMT2C NFATC3 USF2 HNF1A ZEB1 EP400 RBL2 ARNT PBRM1 ARID2 SMARCA2 SUMO3 | 6.98e-06 | 312 | 245 | 15 | int:FOS |
| Interaction | FHL2 interactions | SP3 SP4 POU6F2 IL16 HIPK1 SREBF2 BAP1 USF2 SAP130 EP400 NRF1 RFX1 IFI35 PKNOX2 ATF1 QSER1 SPEN | 7.66e-06 | 396 | 245 | 17 | int:FHL2 |
| Interaction | SP1 interactions | SP3 SP4 ESR2 SREBF2 BAP1 NFYA NFYB TAF4 SAP130 ARHGAP21 REST CDC42BPB ARNT TLN1 SPEN HCFC1 | 1.10e-05 | 365 | 245 | 16 | int:SP1 |
| Interaction | PAX6 interactions | NCOA6 LIN54 ZEB2 BAP1 KMT2C NFRKB SAP130 PRRC2B ZEB1 EP400 PBRM1 ARID2 SMARCA2 SUMO3 QSER1 HDAC10 | 1.14e-05 | 366 | 245 | 16 | int:PAX6 |
| Interaction | ASF1A interactions | NCOA6 LIN54 NFRKB SAP130 RNF169 EP400 NRF1 ARNT ARID2 MDC1 QSER1 SPEN HCFC1 | 1.21e-05 | 249 | 245 | 13 | int:ASF1A |
| Interaction | KLF8 interactions | LIN54 RPS17 ZEB2 BAP1 NFRKB TAF4 SAP130 PRRC2B ZEB1 EP400 FOXP4 PBRM1 ARID2 QSER1 SPEN | 1.31e-05 | 329 | 245 | 15 | int:KLF8 |
| Interaction | PRSS37 interactions | 2.62e-05 | 15 | 245 | 4 | int:PRSS37 | |
| Interaction | AR interactions | NCOA6 ABL1 LIN54 PMEPA1 BAP1 KMT2C UBR5 SQSTM1 NFRKB SAP130 MED13 PRRC2B FN1 EP400 HECTD4 RNF213 BRD3 PCF11 FOXP4 ARNT PBRM1 ARID2 MDC1 SMARCA2 QSER1 HCFC1 KDM1A PCM1 | 3.08e-05 | 992 | 245 | 28 | int:AR |
| Interaction | RCOR1 interactions | ESR2 TNRC6B ANKHD1 BIRC6 ZEB2 BAP1 TRIM66 UBR5 SQSTM1 ARHGAP21 VCPIP1 TTC28 REST NCAPH TET1 SPEN KDM1A PCM1 | 3.73e-05 | 494 | 245 | 18 | int:RCOR1 |
| Interaction | SMG7 interactions | NCOA6 TNRC6B TRIM66 SQSTM1 FGFR3 PRRC2B RC3H2 MLLT10 PCF11 ARNT TET1 PUM1 KDM1A PCM1 | 3.88e-05 | 319 | 245 | 14 | int:SMG7 |
| Interaction | CTNNB1 interactions | ABL1 PDLIM7 ESR2 RPS17 BAP1 FANCC MET TSC22D1 CEP78 PTPRJ UBR5 SQSTM1 NFYA NFYB HERC2 ARHGAP21 VCPIP1 USP53 HNF1A EP400 PKP4 MLLT10 NCAPH ARNT TLN1 LRP5 RAPGEF2 KDM1A | 4.16e-05 | 1009 | 245 | 28 | int:CTNNB1 |
| Interaction | DYNLT1 interactions | ESR2 LIN54 BAP1 NFRKB SAP130 ARHGAP21 NCAPH FARP1 SUMO3 SPEN HCFC1 KDM1A | 4.16e-05 | 241 | 245 | 12 | int:DYNLT1 |
| Interaction | SMARCB1 interactions | IL16 ESR2 UBQLN4 KMT2C UBR5 SQSTM1 VTN BRD3 MLLT10 PBRM1 ARID2 MDC1 SMARCA2 HCFC1 KDM1A | 4.24e-05 | 364 | 245 | 15 | int:SMARCB1 |
| Interaction | YWHAG interactions | VAPB NCOA6 ABL1 ESR2 TNFRSF10A TRIP11 FAM13B LYST BAP1 SH3BP4 KCNQ5 CEP78 NFATC3 SQSTM1 AGFG1 ARHGAP21 BICC1 USP53 RC3H2 HNF1A FN1 TTC28 HECTD4 E2F8 PPP4R4 TET1 MACF1 AKAP13 RAPGEF2 PUM1 PCM1 IL7R | 5.27e-05 | 1248 | 245 | 32 | int:YWHAG |
| Interaction | ADAMTS12 interactions | 5.35e-05 | 55 | 245 | 6 | int:ADAMTS12 | |
| Interaction | CIITA interactions | 5.35e-05 | 55 | 245 | 6 | int:CIITA | |
| Interaction | FOXJ2 interactions | 5.83e-05 | 81 | 245 | 7 | int:FOXJ2 | |
| Interaction | PXN interactions | ABL1 ESR2 TNRC6B BIRC6 TRIP11 SQSTM1 ALK GOLGB1 FN1 TTC28 ARNT TLN1 MACF1 KDM1A | 6.37e-05 | 334 | 245 | 14 | int:PXN |
| Interaction | NUP35 interactions | NCOA6 ESR2 TNRC6B ANKHD1 TRIP11 NUP54 KMT2C SAP130 BICC1 GOLGB1 PRRC2B PCF11 ARNT SMARCA2 QSER1 PUM1 | 6.73e-05 | 424 | 245 | 16 | int:NUP35 |
| Interaction | ARL16 interactions | 6.82e-05 | 83 | 245 | 7 | int:ARL16 | |
| Interaction | PI15 interactions | 6.82e-05 | 83 | 245 | 7 | int:PI15 | |
| Interaction | YAP1 interactions | NCOA6 ABL1 PDLIM7 ESR2 TNRC6B RPS17 SCAF4 KMT2C NFRKB TAF4 SAP130 VCPIP1 ZEB1 TCOF1 NCAPH RFX1 UFM1 PKNOX2 ARNT ARID2 TLN1 MDC1 TET1 SMARCA2 SUMO3 RAPGEF2 SPEN HCFC1 KDM1A | 6.92e-05 | 1095 | 245 | 29 | int:YAP1 |
| Interaction | FBXO38 interactions | 7.23e-05 | 145 | 245 | 9 | int:FBXO38 | |
| Interaction | RAN interactions | ABL1 ESR2 ASH1L RPS17 SSTR3 BAP1 NUP54 BLVRB ADRB2 AGL FN1 SMARCA2 SUMO3 SPEN HCFC1 SLC26A6 KDM1A | 7.65e-05 | 475 | 245 | 17 | int:RAN |
| Interaction | YWHAH interactions | VAPB NCOA6 ABL1 ESR2 TRIP11 LYST BAP1 SH3BP4 KCNQ5 NFATC3 SQSTM1 AGFG1 ARHGAP21 BICC1 WNK2 VCPIP1 USP53 FN1 TTC28 HECTD4 E2F8 PPP4R4 SLC12A2 TET1 MACF1 AKAP13 RAPGEF2 PUM1 PCM1 | 7.74e-05 | 1102 | 245 | 29 | int:YWHAH |
| Interaction | BAG2 interactions | NCOA6 ANKHD1 BAP1 EHD4 TRIM66 SUPT6H NFRKB ARHGAP21 SLC12A6 RC3H2 FN1 BRD3 TEP1 RFX1 ARNT TLN1 MDC1 QSER1 PUM1 SPEN | 7.91e-05 | 622 | 245 | 20 | int:BAG2 |
| Interaction | IRF4 interactions | 7.94e-05 | 85 | 245 | 7 | int:IRF4 | |
| Interaction | ELF4 interactions | 8.22e-05 | 115 | 245 | 8 | int:ELF4 | |
| Interaction | FBXO42 interactions | TRIP11 SQSTM1 AGFG1 GOLGB1 PRRC2B VCPIP1 EP400 TTC28 CCT7 ARID2 MACF1 PCM1 | 8.31e-05 | 259 | 245 | 12 | int:FBXO42 |
| Interaction | PHF21A interactions | SP3 TNRC6B ANKHD1 BIRC6 ZEB2 BAP1 UBR5 SQSTM1 ARHGAP21 GOLGB1 TTC28 TET1 KDM1A PCM1 | 8.45e-05 | 343 | 245 | 14 | int:PHF21A |
| Interaction | ALG13 interactions | TNRC6B CUL9 TRIM66 PRRC2B RC3H2 PCF11 WDFY3 MAPKBP1 PUM1 PCM1 | 8.45e-05 | 183 | 245 | 10 | int:ALG13 |
| Interaction | TBXT interactions | 8.74e-05 | 116 | 245 | 8 | int:TBXT | |
| Interaction | ERG interactions | NCOA6 HIPK1 KMT2C UBR5 HERC2 PRRC2B BRD3 MLLT10 FOXP4 SMARCA2 QSER1 | 9.44e-05 | 223 | 245 | 11 | int:ERG |
| Interaction | YWHAQ interactions | VAPB NCOA6 ABL1 ESR2 UBQLN4 TRIP11 LYST BAP1 SH3BP4 ADRB2 KCNQ5 NFATC3 AGFG1 ARHGAP21 BICC1 GOLGB1 VTN FN1 TTC28 HECTD4 E2F8 PPP4R4 TLN1 TET1 MACF1 AKAP13 RAPGEF2 PUM1 PCM1 | 9.94e-05 | 1118 | 245 | 29 | int:YWHAQ |
| Interaction | INO80C interactions | 1.05e-04 | 39 | 245 | 5 | int:INO80C | |
| Interaction | ELK3 interactions | 1.11e-04 | 120 | 245 | 8 | int:ELK3 | |
| Interaction | SIRT7 interactions | ESR2 CUL9 ANKHD1 BIRC6 UBR5 SUPT6H HERC2 PRRC2B FN1 TCOF1 YTHDC2 PBRM1 TLN1 MDC1 RCL1 SMARCA2 MACF1 PUM1 SPEN HCFC1 KDM1A PCM1 | 1.18e-04 | 744 | 245 | 22 | int:SIRT7 |
| Interaction | PRTN3 interactions | 1.22e-04 | 91 | 245 | 7 | int:PRTN3 | |
| Interaction | MYOD1 interactions | 1.37e-04 | 194 | 245 | 10 | int:MYOD1 | |
| Interaction | UBE2D2 interactions | UBR5 SQSTM1 NFYA HERC2 RC3H2 HECTD4 RNF34 RNF213 UFM1 MECR UBR3 QSER1 TOPORS | 1.49e-04 | 318 | 245 | 13 | int:UBE2D2 |
| Interaction | VEGFA interactions | 1.50e-04 | 66 | 245 | 6 | int:VEGFA | |
| Interaction | TSC22D2 interactions | 1.50e-04 | 66 | 245 | 6 | int:TSC22D2 | |
| Interaction | IL16 interactions | 1.64e-04 | 127 | 245 | 8 | int:IL16 | |
| Interaction | SDF2L1 interactions | GALNS ESR2 BIRC6 BAP1 MET FGFR3 FGFR4 ADGRF1 ALK PCSK9 MAN2B2 LRP5 DCBLD2 | 1.68e-04 | 322 | 245 | 13 | int:SDF2L1 |
| Interaction | GABPB1 interactions | 1.68e-04 | 43 | 245 | 5 | int:GABPB1 | |
| Interaction | SOX9 interactions | 1.83e-04 | 97 | 245 | 7 | int:SOX9 | |
| Interaction | KCNQ3 interactions | 1.87e-04 | 24 | 245 | 4 | int:KCNQ3 | |
| Interaction | MLC1 interactions | 1.87e-04 | 24 | 245 | 4 | int:MLC1 | |
| Interaction | RHOH interactions | VAPB TNFRSF10A TRIP11 EHD4 SH3BP4 MET PTPRJ TAF4 GOLGB1 SLC12A6 PODXL PKP4 AP3M1 CDC42BPB SLC12A2 FARP1 SLC26A6 | 1.88e-04 | 512 | 245 | 17 | int:RHOH |
| Interaction | FGF1 interactions | 1.88e-04 | 44 | 245 | 5 | int:FGF1 | |
| Interaction | RNF168 interactions | 1.95e-04 | 98 | 245 | 7 | int:RNF168 | |
| Interaction | PCDH8 interactions | 2.00e-04 | 10 | 245 | 3 | int:PCDH8 | |
| Interaction | LGALS3BP interactions | CUL9 TNFRSF10A MET TRIM66 SQSTM1 HERC2 ARHGAP21 VCPIP1 FN1 HECTD4 CCT7 REST | 2.10e-04 | 286 | 245 | 12 | int:LGALS3BP |
| Interaction | GPIHBP1 interactions | 2.26e-04 | 133 | 245 | 8 | int:GPIHBP1 | |
| Interaction | RHOF interactions | VAPB ESR2 ITGA2 TNFRSF10A EHD4 SH3BP4 PTPRJ AGFG1 ARHGAP21 GOLGB1 FAT4 PODXL PKP4 AP3M1 CDC42BPB SLC12A2 FARP1 MACF1 QSER1 SLC26A6 | 2.26e-04 | 673 | 245 | 20 | int:RHOF |
| Interaction | SLC1A2 interactions | 2.33e-04 | 46 | 245 | 5 | int:SLC1A2 | |
| Interaction | KMT2C interactions | 2.38e-04 | 134 | 245 | 8 | int:KMT2C | |
| Interaction | DDAH2 interactions | 2.43e-04 | 72 | 245 | 6 | int:DDAH2 | |
| Interaction | NUP43 interactions | NCOA6 LIN54 ASH1L TNRC6B NUP54 UBR5 SUPT6H NFRKB TAF4 DSC1 EP400 CCT7 ZNF711 PBRM1 ARID2 MDC1 RAPGEF2 SPEN HCFC1 | 2.45e-04 | 625 | 245 | 19 | int:NUP43 |
| Interaction | BRD2 interactions | PDLIM7 HMCN2 NFRKB FGFR3 TAF4 RBL2 BRD3 ZNF711 PBRM1 FARP1 ARID2 MDC1 SMARCA2 BICRAL QSER1 | 2.59e-04 | 429 | 245 | 15 | int:BRD2 |
| Interaction | CSNK2A1 interactions | POU6F2 IL16 ESR2 CUL9 BIRC6 LYST ZEB2 BAP1 SUPT6H SQSTM1 NFYA ZEB1 VTN FN1 NRF1 TCOF1 RBL2 BRD3 CREM ARNT MDC1 MACF1 ATF1 HCFC1 KDM1A | 2.72e-04 | 956 | 245 | 25 | int:CSNK2A1 |
| Interaction | YWHAB interactions | VAPB ABL1 ESR2 TRIP11 LYST BAP1 SH3BP4 KCNQ5 NFATC3 SQSTM1 FGFR3 FGFR4 SAP130 ARHGAP21 RC3H2 HNF1A FN1 TTC28 HECTD4 E2F8 PPP4R4 MACF1 AKAP13 RAPGEF2 PUM1 PCM1 | 2.77e-04 | 1014 | 245 | 26 | int:YWHAB |
| Interaction | MBD3 interactions | ACRBP BIRC6 ZEB2 BAP1 NUTM1 SAP130 BRD3 PKNOX2 TET1 SMARCA2 SPEN KDM1A | 2.79e-04 | 295 | 245 | 12 | int:MBD3 |
| Interaction | RNF214 interactions | 2.81e-04 | 104 | 245 | 7 | int:RNF214 | |
| Interaction | CD160 interactions | 2.85e-04 | 48 | 245 | 5 | int:CD160 | |
| Interaction | ATF7IP interactions | 2.90e-04 | 138 | 245 | 8 | int:ATF7IP | |
| Interaction | CREB1 interactions | 2.94e-04 | 254 | 245 | 11 | int:CREB1 | |
| Interaction | TLX1 interactions | 3.00e-04 | 175 | 245 | 9 | int:TLX1 | |
| Interaction | TP53BP1 interactions | NCOA6 POU6F2 ESR2 TRIM22 UBR5 SAGE1 HERC2 SAP130 MED13 RNF169 ZEB1 EP400 RBL2 RFX1 MDC1 TOPORS KDM1A | 3.00e-04 | 533 | 245 | 17 | int:TP53BP1 |
| Interaction | MPRIP interactions | 3.03e-04 | 214 | 245 | 10 | int:MPRIP | |
| Interaction | SFN interactions | NCOA6 ABL1 ESR2 TRIP11 LYST BAP1 SH3BP4 MET KCNQ5 NFATC3 SQSTM1 SAP130 ARHGAP21 VCPIP1 USP53 PPP4R4 ARNT MACF1 AKAP13 PUM1 | 3.24e-04 | 692 | 245 | 20 | int:SFN |
| Interaction | H3-3A interactions | LIN54 ASH1L ZEB2 KMT2C NFRKB TAF4 HERC2 SAP130 HNF1A RNF169 BRD3 RFX1 ZNF711 PBRM1 SBNO1 ARID2 MDC1 QSER1 SPEN HCFC1 KDM1A | 3.44e-04 | 749 | 245 | 21 | int:H3-3A |
| Interaction | TAF8 interactions | 3.46e-04 | 50 | 245 | 5 | int:TAF8 | |
| Interaction | AP3S2 interactions | 3.47e-04 | 28 | 245 | 4 | int:AP3S2 | |
| Interaction | CASP9 interactions | 3.50e-04 | 77 | 245 | 6 | int:CASP9 | |
| Interaction | SDC2 interactions | 3.69e-04 | 143 | 245 | 8 | int:SDC2 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.50e-04 | 161 | 171 | 8 | 593 | |
| GeneFamily | Cadherin related | 5.13e-04 | 17 | 171 | 3 | 24 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.41e-04 | 40 | 171 | 4 | 321 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SP3 ACAP1 IL16 HIPK1 ASH1L TNRC6B BIRC6 FAM13B LYST TRIM22 ZEB2 KMT2C PTPRJ UBR5 NFATC3 AGFG1 PLCB2 USF2 MED13 PRRC2B ZEB1 EP400 RBL2 HECTD4 RNF213 YTHDC2 REST AP3M1 CREM EPG5 PCF11 TGFBR3 SBNO1 SLC20A1 ARID2 TLN1 SMARCA2 MACF1 AKAP13 SPEN PCM1 IL7R | 2.41e-10 | 1492 | 249 | 42 | M40023 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | SP3 ABL1 ADRB2 UBR5 NFYA ZNF264 BTBD3 PCF11 MEGF9 MDC1 BICRAL WDFY3 RAPGEF2 PUM1 SPEN | 2.12e-07 | 300 | 249 | 15 | M8702 |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | VAPB ZKSCAN7 FAM13B LYST TRIM22 TSC22D1 AGL NFYB PRRC2B RBL2 BRD3 WDFY3 | 5.24e-07 | 200 | 249 | 12 | M4456 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | B3GALT2 LIN54 ASH1L ITGA2 TRIP11 LYST ZEB2 EHD4 KMT2C PTPRJ AGFG1 MED13 SLC12A6 RC3H2 APBB2 IFI35 BTBD3 TGFBR3 ARNT SLC12A2 UBR3 MACF1 RAPGEF2 MBD5 EMCN | 7.04e-07 | 854 | 249 | 25 | M1533 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 TSC22D2 ZEB2 UBR5 NFATC3 AGFG1 TAF4 MED13 SEC14L1 ZEB1 TTC28 PODXL PKP4 APBB2 PCF11 TGFBR3 SMARCA2 MACF1 AKAP13 BICRAL WDFY3 RAPGEF2 PUM1 SPEN IL7R | 7.35e-07 | 856 | 249 | 25 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | DNAH14 PKHD1 BICC1 PRUNE2 TTC28 RNF213 FARP1 AKAP13 WDFY3 RAPGEF2 MBD5 | 1.05e-06 | 176 | 249 | 11 | M39223 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | BIRC6 FANCC KMT2C MED13 RIC1 ZEB1 SBNO1 TLN1 MACF1 HCFC1 PCM1 | 1.31e-06 | 180 | 249 | 11 | M8239 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | B3GALT2 LIN54 ASH1L ITGA2 TRIP11 LYST ZEB2 EHD4 KMT2C PTPRJ AGFG1 MED13 SLC12A6 RC3H2 APBB2 IFI35 BTBD3 TGFBR3 ARNT SLC12A2 UBR3 MACF1 RAPGEF2 MBD5 EMCN | 1.42e-06 | 888 | 249 | 25 | MM1018 |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | PDE4A ASH1L CDH23 NFYA FGFR4 PCBP4 PLPPR2 PRRC2B FN1 PODXL SBNO1 FARP1 TLN1 RCL1 MACF1 ATF1 DCBLD2 DCXR KDM1A | 2.13e-06 | 563 | 249 | 19 | M15103 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN | PDLIM7 ZEB2 PLPPR2 VTN FN1 PODXL AGPAT2 ARHGEF25 CDC42BPB MDGA1 SLC26A6 | 3.65e-06 | 200 | 249 | 11 | M7323 |
| Coexpression | GSE17721_POLYIC_VS_CPG_2H_BMDC_DN | UBL7 B3GALT2 SH3BP4 PLPPR2 ARHGAP21 USP53 NCAPH UFM1 RCL1 GMEB1 DCBLD2 | 3.65e-06 | 200 | 249 | 11 | M3939 |
| Coexpression | HAN_SATB1_TARGETS_DN | ABL1 PMEPA1 TSC22D1 ADGRF1 FN1 EP400 RBL2 PAAF1 SBNO1 MDC1 QSER1 GAA PCM1 IL7R C1orf174 | 5.20e-06 | 388 | 249 | 15 | M15491 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | ASH1L TNRC6B PTPRJ PKHD1 GOLGB1 PRUNE2 TTC28 FARP1 AKAP13 WDFY3 MBD5 | 9.45e-06 | 221 | 249 | 11 | M39222 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | ABL1 TRIP11 FANCC MET FGFR3 ALK HNF1A RNF213 MLLT10 ARNT TET1 ATF1 PCM1 | 1.46e-05 | 323 | 249 | 13 | M9150 |
| Coexpression | GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | PDE4A TNRC6B TSC22D2 ZEB2 ADRB2 CEP78 ZNF264 TGFBR3 BICRAL C1orf174 | 1.78e-05 | 194 | 249 | 10 | M6493 |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | MYLK CUL9 TSC22D2 PMEPA1 TRIM22 ADRB2 ADGRF1 BICC1 PODXL SLC12A2 DACH2 SLC20A1 ANGPTL4 MACF1 | 1.95e-05 | 382 | 249 | 14 | M38972 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 2.26e-05 | 60 | 249 | 6 | M1401 | |
| Coexpression | PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7 | ZXDC PDLIM7 TSC22D2 TNFRSF10A PMEPA1 LYST MET HOXC6 KISS1 SLC12A6 E2F8 TET1 ANGPTL4 AKAP13 | 3.14e-05 | 399 | 249 | 14 | M2413 |
| Coexpression | BILD_HRAS_ONCOGENIC_SIGNATURE | TNRC6B ITGA2 TNFRSF10A TRIM22 KMT2C TSC22D1 HOXC6 ADRB2 FN1 SLC20A1 ANGPTL4 | 3.20e-05 | 252 | 249 | 11 | M12029 |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | MYLK ITGA2 PMEPA1 BDKRB2 EHD4 TSC22D1 SEC14L1 ZEB1 PODXL PKP4 REST MACF1 EMCN | 4.76e-05 | 362 | 249 | 13 | M39176 |
| Coexpression | HALLMARK_APICAL_SURFACE | 5.96e-05 | 44 | 249 | 5 | M5916 | |
| Coexpression | KONDO_EZH2_TARGETS | GALNS MYLK TNRC6B ZEB1 TTC28 AOX1 APBB2 SLC12A2 AKAP13 MYO16 | 7.28e-05 | 229 | 249 | 10 | M5301 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 8.06e-05 | 75 | 249 | 6 | MM605 | |
| Coexpression | TBK1.DF_DN | TNRC6B ITGA2 PMEPA1 NFYB AGFG1 PRRC2B TCOF1 PKP4 TLN1 ANGPTL4 SMARCA2 | 9.96e-05 | 286 | 249 | 11 | M2864 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | UBL7 SP3 ABL1 TSC22D2 ZEB2 MET NFYA ZNF264 FGFR4 HERC2 ALK PRRC2B PRUNE2 TTC28 PODXL RBL2 APBB2 APLF PKNOX2 SMARCA2 UBR3 WDFY3 PCM1 | 1.04e-04 | 1009 | 249 | 23 | M157 |
| Coexpression | GABRIELY_MIR21_TARGETS | DDAH1 TNRC6B UBR5 ARHGAP21 YTHDC2 AP3M1 BTBD3 PBRM1 MEGF9 TET1 UBR3 | 1.09e-04 | 289 | 249 | 11 | M2196 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | TSC22D2 MET FGFR4 HERC2 ALK PRRC2B PODXL PKP4 BRD3 MEGF9 MDC1 TOPORS | 1.09e-04 | 340 | 249 | 12 | M2012 |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP | 1.10e-04 | 195 | 249 | 9 | M7226 | |
| Coexpression | GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP | 1.14e-04 | 196 | 249 | 9 | M7687 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.19e-04 | 197 | 249 | 9 | M8980 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP | 1.23e-04 | 198 | 249 | 9 | M7550 | |
| Coexpression | GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN | 1.28e-04 | 199 | 249 | 9 | M9423 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN | 1.28e-04 | 199 | 249 | 9 | M3583 | |
| Coexpression | GSE27786_LIN_NEG_VS_NEUTROPHIL_UP | 1.28e-04 | 199 | 249 | 9 | M4794 | |
| Coexpression | GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN | 1.28e-04 | 199 | 249 | 9 | M4097 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 1.28e-04 | 199 | 249 | 9 | M9236 | |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP | 1.33e-04 | 200 | 249 | 9 | M9522 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP | 1.33e-04 | 200 | 249 | 9 | M8843 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN | 1.33e-04 | 200 | 249 | 9 | M4022 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | PDE4A DDAH1 PMEPA1 TRIM22 SH3BP4 MET HMCN2 PTPRJ TP53I13 KISS1 PRUNE2 APOL1 | 1.63e-04 | 355 | 249 | 12 | M45758 |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 1.72e-04 | 86 | 249 | 6 | M39248 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.79e-04 | 208 | 249 | 9 | M39233 | |
| Coexpression | GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 1.81e-04 | 164 | 249 | 8 | M8989 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 1.97e-04 | 166 | 249 | 8 | M7722 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING | HIPK1 RPS17 ZEB2 EHD4 SQSTM1 PRRC2B ZEB1 BRD3 PBRM1 CSF2RA MACF1 SUMO3 HAMP | 1.99e-04 | 418 | 249 | 13 | MM3752 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | ABL1 MYLK ASH1L ARMCX4 PMEPA1 TSC22D1 ADRB2 KCNK2 RC3H2 ZEB1 FN1 TTC28 REST SLC12A2 CSF2RA SMARCA2 LRP4 MACF1 | 2.01e-04 | 721 | 249 | 18 | M1999 |
| Coexpression | AMIT_SERUM_RESPONSE_240_MCF10A | 2.08e-04 | 57 | 249 | 5 | M2777 | |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP | 2.51e-04 | 172 | 249 | 8 | M2945 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | NCOA6 SP3 HIPK1 ANKHD1 NFYB HERC2 PKP4 YTHDC2 BTBD3 SMARCA2 MACF1 ATF1 WDFY3 | 2.56e-04 | 429 | 249 | 13 | M29 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN | 2.93e-04 | 176 | 249 | 8 | M8884 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP | 2.93e-04 | 176 | 249 | 8 | M7725 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 3.04e-04 | 177 | 249 | 8 | M39245 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | VAPB SP3 MYLK ASH1L BIRC6 PMEPA1 ZEB2 KMT2C HOXC6 RTL3 BICC1 VCPIP1 USP53 RC3H2 RBM45 FAT3 PKP4 REST ZNF711 MECR SLC12A2 MEGF9 TLN1 TET1 SMARCA2 GMEB1 ROBO2 WDFY3 PUM1 TOPORS | 9.86e-09 | 790 | 244 | 30 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | VAPB SP3 SP4 RBM44 ASH1L ANKHD1 BIRC6 ZEB2 HOXC6 BICC1 VCPIP1 USP53 RC3H2 RBM45 PKP4 RNF213 REST PKNOX2 PBRM1 SLC12A2 SBNO1 TET1 GMEB1 ROBO2 WDFY3 PUM1 TOPORS | 6.87e-07 | 806 | 244 | 27 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | VAPB SP3 ASH1L BIRC6 ZEB2 HOXC6 BICC1 RC3H2 RBM45 FAT3 PKP4 MECR SLC12A2 TET1 GMEB1 ROBO2 WDFY3 PUM1 | 1.53e-06 | 413 | 244 | 18 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | VAPB SP3 MYLK ASH1L BIRC6 PMEPA1 ZEB2 KMT2C HOXC6 RTL3 PKHD1 BICC1 USP53 RC3H2 RBM45 FAT3 PKP4 ZNF711 MECR SLC12A2 TET1 SMARCA2 GMEB1 WDFY3 PUM1 TOPORS | 1.91e-06 | 799 | 244 | 26 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | VAPB SP3 SP4 ASH1L BIRC6 PMEPA1 ZEB2 KMT2C HOXC6 PKHD1 BICC1 RC3H2 RBM45 FAT3 PKP4 REST ZNF711 MECR SLC12A2 TET1 SMARCA2 GMEB1 ROBO2 WDFY3 PUM1 TOPORS | 2.00e-06 | 801 | 244 | 26 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | VAPB SP3 SP4 MYLK ASH1L BIRC6 PMEPA1 ZEB2 HOXC6 PKHD1 BICC1 USP53 RC3H2 RBM45 FAT3 PKP4 C4orf54 UFM1 MECR SLC12A2 TET1 SMARCA2 GMEB1 WDFY3 PUM1 | 5.79e-06 | 797 | 244 | 25 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | ZEB2 HOXC6 NYNRIN BICC1 FN1 FAT3 ARHGEF25 CCDC141 PKNOX2 TGFBR3 ROBO2 | 8.76e-06 | 182 | 244 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SP3 RBM44 ASH1L BIRC6 TRIM66 KMT2C AIFM3 VCPIP1 USP53 SLC12A6 RC3H2 RBM45 PKP4 RNF213 YTHDC2 REST CCDC141 ZNF711 MECR SLC12A2 SBNO1 GMEB1 WDFY3 PUM1 | 1.18e-05 | 778 | 244 | 24 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | SP3 SP4 RBM44 ASH1L BIRC6 ZEB2 USP53 RBM45 PKP4 REST SLC12A2 TET1 GMEB1 ROBO2 WDFY3 PUM1 | 1.88e-05 | 403 | 244 | 16 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SP3 RBM44 ASH1L BIRC6 ZEB2 VCPIP1 USP53 RC3H2 RBM45 PODXL PKP4 RNF213 YTHDC2 REST ZNF711 PBRM1 MECR SLC12A2 TET1 GMEB1 ROBO2 WDFY3 PUM1 TOPORS | 2.02e-05 | 804 | 244 | 24 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 2.56e-05 | 31 | 244 | 5 | gudmap_kidney_P0_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | PMEPA1 NYNRIN BICC1 ZEB1 FN1 FAT3 ARHGEF25 CCDC141 ZNF711 ROBO2 | 2.57e-05 | 168 | 244 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SP3 SP4 RBM44 ASH1L ANKHD1 BIRC6 TRIM66 KMT2C NFATC3 AIFM3 VCPIP1 USP53 RC3H2 RBM45 PKP4 RNF213 YTHDC2 ZNF711 MECR SLC12A2 SBNO1 GMEB1 PUM1 | 3.38e-05 | 776 | 244 | 23 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | SP3 RBM44 ASH1L BIRC6 TRIM66 KMT2C AIFM3 USP53 RBM45 PKP4 YTHDC2 ZNF711 MECR SLC12A2 PUM1 | 4.51e-05 | 387 | 244 | 15 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 6.13e-05 | 150 | 244 | 9 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | VAPB SP3 ASH1L BIRC6 ZEB2 PCBP4 VCPIP1 RC3H2 NRF1 RBM45 PKP4 YTHDC2 REST ZNF711 PBRM1 MECR SLC12A2 DACH2 TET1 GMEB1 ROBO2 WDFY3 PUM1 | 7.14e-05 | 815 | 244 | 23 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | UBL7 RBM44 DDAH1 CADM4 UBQLN4 BIRC6 NYNRIN PCBP4 BICC1 RC3H2 TCOF1 RBM45 BRD3 REST AP3M1 FOXP4 SLC20A1 ROBO2 PUM1 TOPORS HCFC1 PCM1 EMCN | 7.68e-05 | 819 | 244 | 23 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | SP3 ASH1L PMEPA1 ZEB2 HOXC6 BICC1 RC3H2 RBM45 FAT3 PKP4 TET1 GMEB1 ROBO2 WDFY3 PUM1 | 7.74e-05 | 406 | 244 | 15 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | SP3 RBM44 ASH1L BIRC6 ZEB2 USP53 RBM45 PKP4 RNF213 ZNF711 PBRM1 SLC12A2 GMEB1 ROBO2 PUM1 | 8.40e-05 | 409 | 244 | 15 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | SP3 RBM44 ASH1L BIRC6 KMT2C PTPRJ KHDC3L AGL AIFM3 USP53 SLC12A6 RBM45 PKP4 RNF213 YTHDC2 REST CCDC141 MECR SLC12A2 GMEB1 WDFY3 PUM1 | 8.62e-05 | 770 | 244 | 22 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | VAPB SP3 ASH1L ZEB2 NRF1 PKP4 ZNF711 PBRM1 MECR SLC12A2 TET1 GMEB1 WDFY3 | 1.00e-04 | 323 | 244 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.30e-04 | 97 | 244 | 7 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.30e-04 | 97 | 244 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 1.40e-04 | 167 | 244 | 9 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.74e-04 | 172 | 244 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | SP3 ASH1L PMEPA1 ZEB2 PKHD1 BICC1 RC3H2 RBM45 FAT3 PKP4 TET1 GMEB1 WDFY3 PUM1 | 2.59e-04 | 404 | 244 | 14 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | MYLK ARMCX4 PMEPA1 ZEB2 HOXC6 NYNRIN BICC1 ZEB1 FN1 FAT3 PON3 RNF213 ARHGEF25 CCDC141 E2F8 PKNOX2 TGFBR3 MDC1 TET1 ROBO2 QSER1 | 2.66e-04 | 777 | 244 | 21 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 2.80e-04 | 28 | 244 | 4 | gudmap_kidney_P2_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | SP3 RBM44 ASH1L BIRC6 TRIM66 KMT2C USP53 RC3H2 RBM45 PODXL PKP4 RNF213 YTHDC2 ZNF711 MECR SLC12A2 SBNO1 GMEB1 WDFY3 PUM1 CTSE | 3.61e-04 | 795 | 244 | 21 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.67e-04 | 151 | 244 | 8 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | SP3 RBM44 BIRC6 USP53 PODXL RNF213 YTHDC2 ZNF711 MECR SLC12A2 | 3.82e-04 | 233 | 244 | 10 | gudmap_developingGonad_e12.5_ovary_k5_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_200 | 3.94e-04 | 13 | 244 | 3 | gudmap_kidney_P2_CapMes_Crym_k1_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | UBL7 DDAH1 CADM4 UBQLN4 NYNRIN BICC1 RC3H2 TCOF1 BRD3 REST AP3M1 FOXP4 PUM1 TOPORS HCFC1 PCM1 | 3.94e-04 | 524 | 244 | 16 | gudmap_developingGonad_e12.5_testes_k1_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 4.19e-04 | 31 | 244 | 4 | gudmap_kidney_P1_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_200 | 4.80e-04 | 120 | 244 | 7 | gudmap_kidney_P1_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.36e-04 | 58 | 244 | 5 | gudmap_kidney_P0_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.57e-04 | 123 | 244 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 5.63e-04 | 161 | 244 | 8 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | LYST MET HOXC6 PTPRJ AGL BICC1 TTC28 FAT3 SLC12A2 MEGF9 ROBO2 | 5.77e-04 | 291 | 244 | 11 | gudmap_kidney_P2_CapMes_Crym_500 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_200 | 5.84e-04 | 124 | 244 | 7 | gudmap_kidney_P0_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 5.90e-04 | 203 | 244 | 9 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.03e-04 | 90 | 244 | 6 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | SP3 DDAH1 ZEB2 TSC22D1 HOXC6 NYNRIN BICC1 FAT4 PODXL FAT3 RNF213 PPP4R4 ZNF711 PCF11 PKNOX2 TGFBR3 FARP1 SMARCA2 ROBO2 QSER1 EMCN | 6.41e-04 | 831 | 244 | 21 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.74e-04 | 127 | 244 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | VAPB B3GALT2 MYLK CADM4 ITGA2 PMEPA1 EHD4 HOXC6 ADRB2 PTPRJ AIFM3 PODXL APBB2 UFM1 TGFBR3 MEGF9 SMARCA2 MACF1 ROBO2 WDFY3 NXPH3 | 7.14e-04 | 838 | 244 | 21 | gudmap_kidney_adult_Podocyte_MafB_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000 | HIPK1 ARMCX4 LYST ZEB2 KCNQ5 ZEB1 TTC28 APBB2 PON3 YTHDC2 SLC12A2 DCBLD2 | 7.39e-04 | 348 | 244 | 12 | gudmap_kidney_adult_Mesangium_Meis_k2_1000 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | HIPK1 ASH1L TNRC6B BIRC6 ZEB2 KMT2C MED13 GOLGB1 RNF213 EPG5 SLC20A1 ARID2 MACF1 RAPGEF2 SPEN | 2.60e-13 | 188 | 252 | 15 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ASH1L BIRC6 PMEPA1 FAM13B TRIM22 KMT2C UBR5 SEC14L1 FAT4 ZEB1 PKP4 RNF213 MACF1 IL7R | 9.75e-12 | 200 | 252 | 14 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IL16 MYLK ITGA2 FGFR4 BICC1 USP53 FAT4 FAT3 AOX1 PKNOX2 MACF1 ROBO2 | 1.05e-09 | 191 | 252 | 12 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | POU6F2 MYLK PRUNE2 FAT4 FN1 AOX1 TGFBR3 DACH2 LRP4 ROBO2 MDGA1 | 7.43e-09 | 181 | 252 | 11 | b116c68393d8836bac080f81a8fcbeb52e0403e7 |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | ASH1L TNRC6B PTPRJ PKHD1 BICC1 TTC28 FARP1 MACF1 AKAP13 RAPGEF2 MBD5 | 1.37e-08 | 192 | 252 | 11 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IL16 MYLK ITGA2 FGFR4 BICC1 USP53 FAT3 AOX1 PKNOX2 MACF1 ROBO2 | 1.37e-08 | 192 | 252 | 11 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | IL16 MYLK FGFR4 BICC1 USP53 FN1 FAT3 AOX1 PKNOX2 MACF1 ROBO2 | 1.45e-08 | 193 | 252 | 11 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | IL16 MYLK CDH23 FGFR4 BICC1 USP53 FAT3 PKNOX2 ANGPTL4 MACF1 ROBO2 | 1.45e-08 | 193 | 252 | 11 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | IL16 MYLK CDH23 FGFR4 BICC1 USP53 FAT3 AOX1 PKNOX2 TGFBR3 ROBO2 | 1.53e-08 | 194 | 252 | 11 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MYLK ZEB2 FANCC FGFR3 FGFR4 BICC1 FN1 FAT3 PPP4R4 MACF1 ROBO2 | 1.61e-08 | 195 | 252 | 11 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MYLK ZEB2 FANCC FGFR3 FGFR4 BICC1 FN1 FAT3 PPP4R4 MACF1 ROBO2 | 1.61e-08 | 195 | 252 | 11 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | IL16 MYLK FGFR4 BICC1 USP53 FN1 FAT3 AOX1 PKNOX2 TGFBR3 ROBO2 | 1.70e-08 | 196 | 252 | 11 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | TNRC6B BIRC6 KMT2C PTPRJ UBR5 TTC28 APBB2 UBR3 WDFY3 RAPGEF2 MBD5 | 1.99e-08 | 199 | 252 | 11 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | IL16 MYLK ITGA2 ZEB2 FGFR4 BICC1 USP53 FN1 FAT3 PKNOX2 ROBO2 | 2.09e-08 | 200 | 252 | 11 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-08 | 200 | 252 | 11 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.50e-08 | 164 | 252 | 10 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.20e-07 | 187 | 252 | 10 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.27e-07 | 188 | 252 | 10 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.33e-07 | 189 | 252 | 10 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.40e-07 | 190 | 252 | 10 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-07 | 192 | 252 | 10 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-07 | 192 | 252 | 10 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.62e-07 | 193 | 252 | 10 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-07 | 195 | 252 | 10 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-07 | 195 | 252 | 10 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-07 | 195 | 252 | 10 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-07 | 195 | 252 | 10 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.78e-07 | 195 | 252 | 10 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.78e-07 | 195 | 252 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.96e-07 | 197 | 252 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.05e-07 | 198 | 252 | 10 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ASH1L BIRC6 TRIM22 ZEB2 KMT2C GOLGB1 RNF213 MACF1 AKAP13 PCM1 | 2.25e-07 | 200 | 252 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-07 | 200 | 252 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.58e-07 | 161 | 252 | 9 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.95e-07 | 171 | 252 | 9 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 6.24e-07 | 172 | 252 | 9 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-07 | 173 | 252 | 9 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-07 | 173 | 252 | 9 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-07 | 173 | 252 | 9 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.32e-07 | 178 | 252 | 9 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.72e-07 | 179 | 252 | 9 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.56e-07 | 181 | 252 | 9 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 9.56e-07 | 181 | 252 | 9 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-06 | 182 | 252 | 9 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.20e-06 | 186 | 252 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.25e-06 | 187 | 252 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-06 | 187 | 252 | 9 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.25e-06 | 187 | 252 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-06 | 190 | 252 | 9 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.43e-06 | 190 | 252 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.49e-06 | 191 | 252 | 9 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.56e-06 | 192 | 252 | 9 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.56e-06 | 192 | 252 | 9 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-06 | 193 | 252 | 9 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.63e-06 | 193 | 252 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.63e-06 | 193 | 252 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.63e-06 | 193 | 252 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.63e-06 | 193 | 252 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-06 | 194 | 252 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 195 | 252 | 9 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 195 | 252 | 9 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.77e-06 | 195 | 252 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 195 | 252 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 195 | 252 | 9 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 195 | 252 | 9 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 195 | 252 | 9 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.85e-06 | 196 | 252 | 9 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-06 | 196 | 252 | 9 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-06 | 196 | 252 | 9 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-06 | 196 | 252 | 9 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-06 | 196 | 252 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-06 | 197 | 252 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.93e-06 | 197 | 252 | 9 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.93e-06 | 197 | 252 | 9 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.93e-06 | 197 | 252 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.01e-06 | 198 | 252 | 9 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.01e-06 | 198 | 252 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.01e-06 | 198 | 252 | 9 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-06 | 198 | 252 | 9 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.01e-06 | 198 | 252 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.01e-06 | 198 | 252 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-06 | 199 | 252 | 9 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 252 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 252 | 9 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.18e-06 | 200 | 252 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 252 | 9 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 252 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 252 | 9 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.18e-06 | 200 | 252 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 252 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 252 | 9 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 252 | 9 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.18e-06 | 200 | 252 | 9 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 3.55e-06 | 159 | 252 | 8 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.71e-06 | 160 | 252 | 8 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | ASK440-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.16e-06 | 122 | 252 | 7 | 2f76ec3b527e9528fbb006599a96e8bbdf9e0e62 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-06 | 172 | 252 | 8 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-06 | 172 | 252 | 8 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 123 | 252 | 7 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.89e-06 | 174 | 252 | 8 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| Computational | Genes in the cancer module 123. | SP4 ESR2 TSC22D2 ZEB2 TSC22D1 ADRB2 NFYA ZNF264 TAF4 HNF1A NRF1 GRM1 ARNT ZNF646 | 2.61e-05 | 247 | 165 | 14 | MODULE_123 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.09e-04 | 50 | 165 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | VAPB SP4 ASH1L LYST MET AGFG1 ZNF264 SEC14L1 ZEB1 PKP4 REST TEP1 AKAP13 RAPGEF2 SPEN GABPB1 | 3.50e-10 | 191 | 248 | 16 | 4283_DN |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | VAPB MET AGFG1 SEC14L1 RC3H2 RBL2 PKP4 REST MLLT10 SBNO1 AKAP13 SPEN DCBLD2 PCM1 GABPB1 | 3.30e-09 | 192 | 248 | 15 | 4268_DN |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; HL60; HT_HG-U133A | CUL9 TRIP11 MAPK8IP3 SEC14L1 RC3H2 AGPAT2 HECTD4 MLLT10 ARNT SBNO1 LRP5 RAPGEF2 PCM1 | 2.14e-07 | 193 | 248 | 13 | 2561_DN |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | CUL9 TRIP11 SCAF4 NFRKB FGFR3 PLPPR2 APBB2 MLLT10 IFI35 ARNT SMARCA2 GMEB1 GABPB1 | 2.72e-07 | 197 | 248 | 13 | 2641_DN |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | DDAH1 HIPK1 TRIP11 AGFG1 RC3H2 EP400 BRD3 E2F8 LRP5 BICRAL WDFY3 SPEN PCM1 | 2.88e-07 | 198 | 248 | 13 | 1070_DN |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | MAPK8IP3 BAP1 SCAF4 SLC12A5 FANCC USF2 VCPIP1 NRF1 TTC28 REST CREM SMARCA2 PCM1 | 3.05e-07 | 199 | 248 | 13 | 2769_DN |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | VAPB ZXDC PDLIM7 PCBP4 ADGRF1 FN1 REST E2F8 PCF11 FARP1 BICRAL WDFY3 | 8.92e-07 | 184 | 248 | 12 | 4430_DN |
| Drug | 6-bromocyclohex-4-ene-1,2,3-triol | 1.36e-06 | 33 | 248 | 6 | CID000122062 | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; HL60; HG-U133A | TSC22D2 LYST AGL AGFG1 ZNF264 SAP130 MED13 PRRC2B RBL2 SLC12A2 RAPGEF2 TOPORS | 1.48e-06 | 193 | 248 | 12 | 1375_DN |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | SLC17A2 PDE4A MYLK MAPK8IP3 NFRKB AGPAT2 ZNF711 ARNT FARP1 WDFY3 HAMP PCM1 | 1.74e-06 | 196 | 248 | 12 | 6065_DN |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A | MAPK8IP3 NFATC3 ALK BICC1 SFTPB APBB2 PPP4R4 IGHMBP2 LRP4 HAMP RAPGEF2 PCM1 | 1.74e-06 | 196 | 248 | 12 | 5974_DN |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | CUL9 TRIP11 LYST MET PLPPR2 SLC12A6 AGPAT2 YTHDC2 MEGF9 AKAP13 RAPGEF2 SAYSD1 | 1.83e-06 | 197 | 248 | 12 | 1508_DN |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | CADM4 TSC22D2 LYST MAPK8IP3 NYNRIN ALK PRUNE2 ZEB1 SFTPB LRP4 CTSE NXPH3 | 1.93e-06 | 198 | 248 | 12 | 6037_UP |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | VAPB TSC22D2 MET USF2 FN1 RBL2 PKP4 PPP4R4 TLN1 AKAP13 SPEN GABPB1 | 1.93e-06 | 198 | 248 | 12 | 4282_DN |
| Drug | Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; PC3; HT_HG-U133A | ZXDC ASH1L TRIP11 LYST TRIM66 FGFR4 PCBP4 KISS1 RC3H2 AGPAT2 MEGF9 BICRAL | 1.93e-06 | 198 | 248 | 12 | 7272_DN |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; HL60; HT_HG-U133A | TNRC6B ITGA2 TRIP11 SQSTM1 USF2 SEC14L1 APBB2 GRM1 CREM PPP4R4 TGFBR3 QSER1 | 1.93e-06 | 198 | 248 | 12 | 3092_DN |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | SP4 CUL9 LYST MET AGFG1 HNF1A SFTPB REST PPP4R4 GMEB1 SAYSD1 SPEN | 1.93e-06 | 198 | 248 | 12 | 4343_UP |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | PDLIM7 ITGA2 NFATC3 AMT ZEB1 TTC28 APBB2 PPP4R4 TGFBR3 ARNT WDFY3 HCFC1 | 1.93e-06 | 198 | 248 | 12 | 5684_DN |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; PC3; HT_HG-U133A | CUL9 NFRKB AP3M2 FGFR4 USF2 SEC14L1 EP400 TTC28 APBB2 ARNT FARP1 HCFC1 | 1.93e-06 | 198 | 248 | 12 | 7244_DN |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | ITGA2 FANCC USF2 NRF1 APBB2 IGHMBP2 TLN1 SMARCA2 AKAP13 WDFY3 PUM1 GAA | 2.04e-06 | 199 | 248 | 12 | 5283_DN |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | SCAF4 NFYB USF2 PLPPR2 SLC12A6 AGPAT2 MLLT10 CREM FARP1 AKAP13 HCFC1 PCM1 | 2.15e-06 | 200 | 248 | 12 | 7129_DN |
| Drug | myristicin | 2.74e-06 | 10 | 248 | 4 | CID000004276 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | MET AGFG1 ZNF264 SEC14L1 RC3H2 ZEB1 RBL2 PKP4 RAPGEF2 SPEN IL7R | 7.27e-06 | 188 | 248 | 11 | 6735_DN |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; HL60; HG-U133A | ASH1L TNRC6B USF2 RC3H2 MACF1 MAPKBP1 RAPGEF2 PUM1 HCFC1 PCM1 GABPB1 | 8.04e-06 | 190 | 248 | 11 | 1990_DN |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | VAPB LYST MET AGFG1 SEC14L1 RBL2 PKP4 TEP1 SBNO1 AKAP13 SPEN | 8.04e-06 | 190 | 248 | 11 | 4307_DN |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | VAPB MET AGFG1 ZNF264 USF2 SEC14L1 REST TEP1 WDFY3 RAPGEF2 SPEN | 8.45e-06 | 191 | 248 | 11 | 4303_DN |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | MET NFYA AGFG1 ZNF264 USF2 PRRC2B TTC28 MECR BICRAL HCFC1 IL7R | 8.45e-06 | 191 | 248 | 11 | 2055_DN |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | VAPB NFYA SFTPB RBL2 PKP4 AGPAT2 ARNT SMARCA2 AKAP13 SPEN PCM1 | 8.88e-06 | 192 | 248 | 11 | 6435_DN |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | VAPB MET AGFG1 SEC14L1 RC3H2 RBL2 REST AKAP13 RAPGEF2 SPEN GABPB1 | 9.79e-06 | 194 | 248 | 11 | 4312_DN |
| Drug | Sp 1 (pharmaceutical) | SP3 SP4 ESR2 ZKSCAN7 PMEPA1 NFYB TAF4 USF2 KISS1 MED13 HNF1A ZEB1 NRF1 RBL2 APOL1 SLC20A1 MDC1 HDAC10 HCFC1 | 1.00e-05 | 548 | 248 | 19 | CID000099040 |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | SCAF4 TRIM66 FGFR4 FAT4 MLLT10 ZNF711 SMARCA2 GMEB1 RAPGEF2 SAYSD1 PCM1 | 1.03e-05 | 195 | 248 | 11 | 4220_DN |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | ITGA2 TRIP11 NYNRIN NFYA USF2 TTC28 REST GRM1 ARNT RAPGEF2 SAYSD1 | 1.03e-05 | 195 | 248 | 11 | 2317_DN |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; PC3; HT_HG-U133A | SQSTM1 USF2 RC3H2 ZEB1 NRF1 RBL2 APBB2 MLLT10 SMARCA2 GMEB1 AKAP13 | 1.03e-05 | 195 | 248 | 11 | 5089_DN |
| Drug | Ebselen [60940-34-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | FANCC MET NFRKB PLPPR2 AGPAT2 APBB2 YTHDC2 REST GMEB1 SAYSD1 PCM1 | 1.03e-05 | 195 | 248 | 11 | 3458_DN |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | PDE4A PDLIM7 LYST USF2 VCPIP1 SFTPB APBB2 REST ARNT TLN1 PCM1 | 1.03e-05 | 195 | 248 | 11 | 2820_DN |
| Drug | Felbinac [5728-52-9]; Down 200; 18.8uM; MCF7; HT_HG-U133A | TNRC6B TSC22D2 NFATC3 FGFR4 APBB2 YTHDC2 IFI35 AKAP13 WDFY3 HAMP HCFC1 | 1.08e-05 | 196 | 248 | 11 | 5700_DN |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A | PDLIM7 CUL9 MAPK8IP3 BAP1 USF2 PLPPR2 PRRC2B APBB2 HCFC1 PCM1 GABPB1 | 1.08e-05 | 196 | 248 | 11 | 5833_DN |
| Drug | Monocrotaline [315-22-0]; Down 200; 12.2uM; PC3; HT_HG-U133A | PDLIM7 CUL9 SCAF4 MET NFRKB USF2 AGPAT2 APBB2 MLLT10 NCAPH IL7R | 1.08e-05 | 196 | 248 | 11 | 7127_DN |
| Drug | Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; MCF7; HT_HG-U133A | ZXDC PDE4A TSC22D2 LYST MET FGFR4 USF2 REST CREM MAPKBP1 SLC26A6 | 1.08e-05 | 196 | 248 | 11 | 7224_DN |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | CUL9 LYST MET NFRKB AOX1 REST ARNT AKAP13 QSER1 MAPKBP1 HCFC1 | 1.08e-05 | 196 | 248 | 11 | 2775_DN |
| Drug | haloperidol; Down 200; 10uM; PC3; HT_HG-U133A | PDLIM7 ESR2 MAPK8IP3 ZEB1 FN1 NRF1 SFTPB AGPAT2 YTHDC2 REST ARNT | 1.08e-05 | 196 | 248 | 11 | 4427_DN |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | PDLIM7 SREBF2 TNRC6B NFATC3 SUPT6H FGFR4 PODXL YTHDC2 TEP1 PKNOX2 TLN1 | 1.08e-05 | 196 | 248 | 11 | 3383_DN |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | PDLIM7 TNRC6B PRRC2B FN1 NRF1 SFTPB AGPAT2 GRM1 TEP1 HCFC1 PCM1 | 1.13e-05 | 197 | 248 | 11 | 5025_DN |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | LYST MET NFYA USF2 AGPAT2 APBB2 IFI35 CREM ARNT MEGF9 SMARCA2 | 1.13e-05 | 197 | 248 | 11 | 3174_DN |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | CUL9 SCAF4 FGFR4 USF2 PLPPR2 NRF1 PODXL APBB2 PPP4R4 RAPGEF2 GAA | 1.13e-05 | 197 | 248 | 11 | 3247_UP |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | MYLK CUL9 MAPK8IP3 AGPAT2 REST IFI35 ARNT SMARCA2 AKAP13 WDFY3 HCFC1 | 1.19e-05 | 198 | 248 | 11 | 6083_DN |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | TSC22D2 KCNQ3 ALK HNF1A ZEB1 FN1 LRP4 SAYSD1 DCBLD2 PCM1 ZNF646 | 1.19e-05 | 198 | 248 | 11 | 3842_UP |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | TSC22D2 MET SUPT6H NFYA YTHDC2 MLLT10 IGHMBP2 SMARCA2 SLC26A6 PCM1 GABPB1 | 1.19e-05 | 198 | 248 | 11 | 7256_UP |
| Drug | (1)-Nipecotic acid [498-95-3]; Up 200; 31uM; PC3; HT_HG-U133A | MAPK8IP3 SQSTM1 ZEB1 REST PPP4R4 SMARCA2 AKAP13 QSER1 HAMP SAYSD1 HCFC1 | 1.19e-05 | 198 | 248 | 11 | 7296_UP |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; PC3; HT_HG-U133A | MYLK TRIP11 SCAF4 MET NFRKB NFYA AGFG1 PLPPR2 NRF1 SFTPB AKAP13 | 1.19e-05 | 198 | 248 | 11 | 1824_DN |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | PDLIM7 ASH1L BAP1 NFRKB APBB2 REST MLLT10 ARNT GMEB1 HCFC1 SLC26A6 | 1.19e-05 | 198 | 248 | 11 | 7008_UP |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | PDLIM7 SCAF4 ZEB1 AGPAT2 AOX1 CREM PPP4R4 PCF11 BICRAL SAYSD1 TOPORS | 1.19e-05 | 198 | 248 | 11 | 3540_DN |
| Drug | Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A | ASH1L SQSTM1 FGFR4 FN1 REST CREM MEGF9 FARP1 TLN1 BICRAL SLC26A6 | 1.24e-05 | 199 | 248 | 11 | 7215_DN |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | TNRC6B TSC22D2 TRIP11 SCAF4 SUPT6H PLPPR2 SEC14L1 CREM AKAP13 WDFY3 HAMP | 1.24e-05 | 199 | 248 | 11 | 2550_DN |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | PDLIM7 CUL9 ITGA2 BAP1 MET USF2 PCBP4 AGPAT2 YTHDC2 MAPKBP1 RAPGEF2 | 1.24e-05 | 199 | 248 | 11 | 1528_DN |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A | PDLIM7 TSC22D2 UBR5 USF2 SEC14L1 AMT FN1 BRD3 PUM1 TOPORS GABPB1 | 1.30e-05 | 200 | 248 | 11 | 2027_DN |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; HL60; HG-U133A | TSC22D2 TSC22D1 ADRB2 NFYA USF2 MED13 PRRC2B RBL2 PKP4 RAPGEF2 HCFC1 | 1.30e-05 | 200 | 248 | 11 | 1376_DN |
| Drug | dicyclohexyl phthalate | VAPB B3GALT2 SP3 IL16 ESR2 PMEPA1 BDKRB2 TSC22D1 ADRB2 NFYA FGFR4 KISS1 ALK SLC12A6 AOX1 REST E2F8 PBRM1 SLC12A2 TLN1 ABCB11 AKAP13 CTSE SLC26A6 | 1.63e-05 | 836 | 248 | 24 | ctd:C036042 |
| Drug | Succimer | ACAP1 MYLK PDLIM7 ASH1L TNRC6B RPS17 TRIP11 PMEPA1 FAM13B TRIM22 ZEB2 BLVRB TSC22D1 NFATC3 SQSTM1 MED13 VCPIP1 RC3H2 VTN FN1 AOX1 RNF213 REST MLLT10 IFI35 E2F8 UBR3 QSER1 DCBLD2 PCM1 GABPB1 | 2.08e-05 | 1264 | 248 | 31 | ctd:D004113 |
| Drug | Methamphetamine | DDAH1 ABL1 MYLK ACRBP PDLIM7 LIN54 CUL9 PMEPA1 MAPK8IP3 NFATC3 SUPT6H SQSTM1 FGFR3 HERC2 PCBP4 PLPPR2 GOLGB1 SEC14L1 PRUNE2 FN1 EP400 NRF1 PODXL MLLT10 GRM1 GRM5 ARHGEF25 CREM MACF1 AKAP13 HDAC10 PUM1 NXPH3 | 2.49e-05 | 1401 | 248 | 33 | ctd:D008694 |
| Drug | Potassium Chloride | 2.49e-05 | 6 | 248 | 3 | DB00761 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.70e-05 | 178 | 248 | 10 | 3998_DN | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; HL60; HG-U133A | GALNS PDLIM7 TSC22D2 NFATC3 SUPT6H PLPPR2 EP400 CREM AKAP13 BICRAL | 2.97e-05 | 180 | 248 | 10 | 1752_UP |
| Drug | Magnetite Nanoparticles | ACAP1 MYLK PDLIM7 ASH1L TNRC6B RPS17 TRIP11 PMEPA1 FAM13B TRIM22 ZEB2 BLVRB TSC22D1 NFATC3 SQSTM1 MED13 VCPIP1 RC3H2 VTN FN1 AOX1 RNF213 REST MLLT10 IFI35 E2F8 UBR3 QSER1 DCBLD2 PCM1 GABPB1 | 4.10e-05 | 1310 | 248 | 31 | ctd:D058185 |
| Drug | CDPPB | 4.33e-05 | 7 | 248 | 3 | CID011245456 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 4.49e-05 | 189 | 248 | 10 | 4271_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 4.70e-05 | 190 | 248 | 10 | 4507_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | VAPB HIPK1 MET AGFG1 SEC14L1 APBB2 REST MLLT10 AKAP13 RAPGEF2 | 4.91e-05 | 191 | 248 | 10 | 4279_DN |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 4.91e-05 | 191 | 248 | 10 | 4273_DN | |
| Drug | vinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A | 5.13e-05 | 192 | 248 | 10 | 7556_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 5.13e-05 | 192 | 248 | 10 | 5058_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | ASH1L MET NFATC3 NFRKB USF2 ADGRF1 MLLT10 SMARCA2 MACF1 BICRAL | 5.36e-05 | 193 | 248 | 10 | 6751_DN |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 5.60e-05 | 194 | 248 | 10 | 5610_UP | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A | TNRC6B CUL9 TRIP11 FANCC AGPAT2 CDC42BPB SMARCA2 GMEB1 BICRAL IL7R | 5.60e-05 | 194 | 248 | 10 | 4572_DN |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | TRIP11 SCAF4 FANCC TTC28 REST TGFBR3 ARNT LRP5 AKAP13 SAYSD1 | 5.60e-05 | 194 | 248 | 10 | 5384_DN |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | PDE4A BAP1 SLC12A5 FGFR4 PLPPR2 CREM TLN1 SMARCA2 WDFY3 GABPB1 | 5.60e-05 | 194 | 248 | 10 | 3460_DN |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A | 5.60e-05 | 194 | 248 | 10 | 2520_DN | |
| Drug | Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A | SP4 PDLIM7 MAPK8IP3 NFATC3 PLPPR2 VCPIP1 AMT APBB2 REST GRM1 | 5.60e-05 | 194 | 248 | 10 | 2825_UP |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | TSC22D2 SCAF4 NFYA FN1 REST ARNT IGHMBP2 SMARCA2 MAPKBP1 SPEN | 5.60e-05 | 194 | 248 | 10 | 3274_DN |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 5.60e-05 | 194 | 248 | 10 | 7196_DN | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 5.60e-05 | 194 | 248 | 10 | 3431_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | VAPB PDLIM7 MAPK8IP3 SUPT6H NYNRIN USF2 FN1 TGFBR3 SAYSD1 PCM1 | 5.85e-05 | 195 | 248 | 10 | 3393_DN |
| Drug | Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; HL60; HG-U133A | 5.85e-05 | 195 | 248 | 10 | 1731_UP | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 5.85e-05 | 195 | 248 | 10 | 3670_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | ASH1L AGFG1 PRRC2B TTC28 REST MLLT10 CREM GMEB1 WDFY3 SAYSD1 | 5.85e-05 | 195 | 248 | 10 | 5109_DN |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A | MYLK ASH1L ITGA2 MAPK8IP3 NFYA TTC28 REST AKAP13 MAPKBP1 HCFC1 | 5.85e-05 | 195 | 248 | 10 | 4692_DN |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | 5.85e-05 | 195 | 248 | 10 | 2956_DN | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 5.85e-05 | 195 | 248 | 10 | 6163_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; HL60; HT_HG-U133A | TNRC6B TSC22D2 NFATC3 NFYA PLPPR2 RC3H2 SLC12A2 AKAP13 WDFY3 PCM1 | 5.85e-05 | 195 | 248 | 10 | 2358_DN |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A | TRIP11 LYST FANCC NFATC3 NFYA RC3H2 SMARCA2 GMEB1 MACF1 TOPORS | 6.10e-05 | 196 | 248 | 10 | 2511_DN |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 6.10e-05 | 196 | 248 | 10 | 7226_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; HL60; HG-U133A | PDE4A PDLIM7 ADRB2 SUPT6H AP3M2 USF2 PRRC2B MAN2B2 MECR AKAP13 | 6.10e-05 | 196 | 248 | 10 | 2044_DN |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 6.10e-05 | 196 | 248 | 10 | 3233_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | PDLIM7 TRIP11 NFRKB FGFR4 SEC14L1 AGPAT2 CREM ARNT IGHMBP2 GABPB1 | 6.10e-05 | 196 | 248 | 10 | 1487_DN |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 6.10e-05 | 196 | 248 | 10 | 4415_DN | |
| Drug | LY 294002; Down 200; 0.1uM; PC3; HT_HG-U133A | SREBF2 TRIM66 NFATC3 SUPT6H USF2 ADGRF1 EP400 TTC28 SFTPB FARP1 | 6.10e-05 | 196 | 248 | 10 | 1216_DN |
| Drug | Pentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | SLC17A2 PDLIM7 TSC22D2 NFYA SEC14L1 IFI35 PPP4R4 PKNOX2 TGFBR3 ARNT | 6.10e-05 | 196 | 248 | 10 | 6021_UP |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 6.10e-05 | 196 | 248 | 10 | 3256_UP | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; HL60; HT_HG-U133A | 6.10e-05 | 196 | 248 | 10 | 2374_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | CUL9 MAPK8IP3 FANCC SUPT6H USF2 AGPAT2 APBB2 MECR BICRAL HCFC1 | 6.10e-05 | 196 | 248 | 10 | 4539_DN |
| Disease | obsolete_red blood cell distribution width | SLC17A2 SP3 ABL1 LIN54 CDH23 BIRC6 SQSTM1 NFRKB USF2 ARHGAP21 HNF1A EP400 NRF1 TTC28 HECTD4 BRD3 REST APLF EPG5 PBRM1 SLC12A2 ANGPTL4 RCL1 SMARCA2 ABCB11 LRP5 AKAP13 SUMO3 HAMP MYO16 | 9.56e-07 | 1347 | 245 | 30 | EFO_0005192 |
| Disease | Malignant neoplasm of prostate | IL16 ACRBP ESR2 ASH1L TNFRSF10A BAP1 MET KMT2C ADRB2 FGFR4 PODXL AOX1 FOXP4 SLC12A2 ARID2 ROBO2 AKAP13 SPEN DCXR | 1.13e-06 | 616 | 245 | 19 | C0376358 |
| Disease | Prostatic Neoplasms | IL16 ACRBP ESR2 ASH1L TNFRSF10A BAP1 MET KMT2C ADRB2 FGFR4 PODXL AOX1 FOXP4 SLC12A2 ARID2 ROBO2 AKAP13 SPEN DCXR | 1.13e-06 | 616 | 245 | 19 | C0033578 |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 1.13e-06 | 23 | 245 | 5 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 1.13e-06 | 23 | 245 | 5 | C0393682 | |
| Disease | Uncinate Epilepsy | 1.13e-06 | 23 | 245 | 5 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 1.13e-06 | 23 | 245 | 5 | C0014556 | |
| Disease | serum gamma-glutamyl transferase measurement | SP3 ASH1L TNFRSF10A PMEPA1 MET SLC24A4 PKHD1 TAF4 ARHGAP21 MED13 BICC1 HNF1A ZEB1 SFTPB HECTD4 CDC42BPB PBRM1 SBNO1 TLN1 ABCB11 AKAP13 SUMO3 KDM1A | 2.68e-06 | 914 | 245 | 23 | EFO_0004532 |
| Disease | Schizophrenia | SP4 PDE4A ESR2 SREBF2 CHRM4 SLC12A5 MET KCNQ3 ALK REST GRM1 GRM5 PKNOX2 PBRM1 SLC12A2 CSF2RA SBNO1 TET1 SMARCA2 MDGA1 MYO16 PCM1 | 5.21e-06 | 883 | 245 | 22 | C0036341 |
| Disease | pulse pressure measurement | DDAH1 TTC16 LIN54 TNRC6B TSC22D2 MET TRIM66 KCNQ5 SUPT6H BICC1 RC3H2 FN1 TTC28 PODXL FAT3 RNF213 ARHGEF25 CCDC141 TGFBR3 PBRM1 SLC12A2 TET1 ABCB11 UBR3 AKAP13 MBD5 HCFC1 KDM1A PCM1 | 5.40e-06 | 1392 | 245 | 29 | EFO_0005763 |
| Disease | coronary artery disease | NCOA6 PMEPA1 ZEB2 MAPK8IP3 PTPRJ PKHD1 PLCB2 SAP130 ALK ARHGAP21 BICC1 WNK2 PCSK9 HNF1A FAT4 ZEB1 FN1 HECTD4 RNF213 REST EPG5 FARP1 ANGPTL4 AKAP13 RAPGEF2 SAYSD1 | 7.95e-06 | 1194 | 245 | 26 | EFO_0001645 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.49e-05 | 148 | 245 | 8 | C0279702 | |
| Disease | Malignant neoplasm of breast | NCOA6 ACAP1 ABL1 PDLIM7 ESR2 SREBF2 ZEB2 BAP1 HERC2 ALK GOLGB1 ZEB1 FN1 APOL1 EPG5 FOXP4 PBRM1 SBNO1 FARP1 ANGPTL4 MACF1 SPEN ZNF646 | 3.52e-05 | 1074 | 245 | 23 | C0006142 |
| Disease | Stomach Neoplasms | SREBF2 BAP1 BLVRB MET KMT2C ADRB2 UBR5 KISS1 FAT4 CCT7 DCBLD2 | 4.25e-05 | 297 | 245 | 11 | C0038356 |
| Disease | Intrahepatic Cholangiocarcinoma | 4.32e-05 | 24 | 245 | 4 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 4.32e-05 | 24 | 245 | 4 | C3805278 | |
| Disease | Malignant neoplasm of stomach | SREBF2 BAP1 BLVRB MET KMT2C ADRB2 UBR5 KISS1 FAT4 CCT7 DCBLD2 | 4.65e-05 | 300 | 245 | 11 | C0024623 |
| Disease | red blood cell density measurement | SP3 SP4 ESR2 LIN54 TNRC6B ADGRV1 ZEB2 CEP78 UBR5 PKHD1 HNF1A EP400 PODXL PKP4 PBRM1 ARID2 RCL1 AKAP13 SAYSD1 MYO16 | 5.16e-05 | 880 | 245 | 20 | EFO_0007978 |
| Disease | Cholangiocarcinoma | 6.01e-05 | 26 | 245 | 4 | C0206698 | |
| Disease | urate measurement | NCOA6 UBQLN4 ASH1L ADGRV1 BIRC6 QRICH2 NFATC3 PKHD1 FGFR4 BICC1 PRRC2B HNF1A PODXL HECTD4 ARHGEF25 APLF LRP4 AKAP13 SAYSD1 MBD5 | 6.51e-05 | 895 | 245 | 20 | EFO_0004531 |
| Disease | extrahepatic bile duct adenocarcinoma (is_implicated_in) | 6.87e-05 | 2 | 245 | 2 | DOID:3495 (is_implicated_in) | |
| Disease | diet measurement | NCOA6 TNRC6B DNAH14 TMCO4 TRIM66 KCNQ5 PKHD1 PCSK9 NRF1 MLLT10 GRM5 APLF CCDC195 ARID2 SMARCA2 UBR3 ROBO2 SAYSD1 MBD5 MDGA1 MYO16 EMCN | 7.10e-05 | 1049 | 245 | 22 | EFO_0008111 |
| Disease | Renal Cell Carcinoma | 1.01e-04 | 128 | 245 | 7 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.01e-04 | 128 | 245 | 7 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.01e-04 | 128 | 245 | 7 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.01e-04 | 128 | 245 | 7 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.01e-04 | 128 | 245 | 7 | C1306837 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.39e-04 | 32 | 245 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | SLC17A2 LIN54 TNRC6B ZEB2 UBR5 USF2 ARHGAP21 MED13 GOLGB1 EP400 TTC28 HECTD4 BRD3 E2F8 RCL1 ABCB11 LRP5 MACF1 AKAP13 HAMP MYO16 GAA | 1.49e-04 | 1105 | 245 | 22 | EFO_0004528 |
| Disease | Neoplasm Invasiveness | 1.61e-04 | 184 | 245 | 8 | C0027626 | |
| Disease | myocardial infarction | PMEPA1 ZEB2 PLCB2 PCSK9 HNF1A FN1 HECTD4 REST ANGPTL4 SAYSD1 GAA | 1.81e-04 | 350 | 245 | 11 | EFO_0000612 |
| Disease | Hereditary Diffuse Gastric Cancer | 1.84e-04 | 293 | 245 | 10 | C1708349 | |
| Disease | cysteine-rich hydrophobic domain-containing protein 2 measurement | 2.05e-04 | 3 | 245 | 2 | EFO_0801510 | |
| Disease | Clear cell papillary renal cell carcinoma | 2.05e-04 | 3 | 245 | 2 | C4518333 | |
| Disease | amyloid beta A4 precursor protein-binding family B member 3 measurement | 2.05e-04 | 3 | 245 | 2 | EFO_0802276 | |
| Disease | hair colour measurement | IL16 GALNS ADGRV1 TRIP11 LYST SLC24A4 PKHD1 HERC2 PODXL GRM5 EPG5 IGHMBP2 LRP5 AKAP13 QSER1 | 2.15e-04 | 615 | 245 | 15 | EFO_0007822 |
| Disease | venous thromboembolism, fibrinogen measurement | 2.41e-04 | 67 | 245 | 5 | EFO_0004286, EFO_0004623 | |
| Disease | melanoma | 2.46e-04 | 248 | 245 | 9 | C0025202 | |
| Disease | renal cell carcinoma (is_implicated_in) | 2.76e-04 | 69 | 245 | 5 | DOID:4450 (is_implicated_in) | |
| Disease | apolipoprotein A 1 measurement | POU6F2 LIN54 TSC22D2 PMEPA1 NFATC3 FGFR4 PCSK9 HNF1A VTN BRD3 GRM5 ARHGEF25 SBNO1 ANGPTL4 ABCB11 MACF1 ATF1 SAYSD1 | 2.83e-04 | 848 | 245 | 18 | EFO_0004614 |
| Disease | Colorectal Carcinoma | ACAP1 GALNS ESR2 ZEB2 SLC12A5 KMT2C KCNQ5 PKHD1 FGFR3 PLPPR2 FN1 TCOF1 GRM1 ARNT ABCB11 GABPB1 | 2.84e-04 | 702 | 245 | 16 | C0009402 |
| Disease | intraocular pressure measurement | SYNDIG1L POU6F2 TSC22D2 PMEPA1 MAPK8IP3 PTPRJ PKHD1 HERC2 BICC1 BRD3 LRP4 AKAP13 EMCN | 3.65e-04 | 509 | 245 | 13 | EFO_0004695 |
| Disease | Hereditary pulmonary alveolar proteinosis | 4.07e-04 | 4 | 245 | 2 | cv:C3711368 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 4.07e-04 | 4 | 245 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Adenocarcinoma | 4.27e-04 | 116 | 245 | 6 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 4.27e-04 | 116 | 245 | 6 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 4.27e-04 | 116 | 245 | 6 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 4.27e-04 | 116 | 245 | 6 | C0205642 | |
| Disease | Carcinoma, Cribriform | 4.27e-04 | 116 | 245 | 6 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 4.27e-04 | 116 | 245 | 6 | C0205641 | |
| Disease | testosterone measurement | SLC17A2 NCOA6 PDE4A ESR2 UBQLN4 TSC22D2 BIRC6 PMEPA1 KCNQ5 PTPRJ NYNRIN TAF4 KISS1 ARHGAP21 HNF1A KIF27 TTC28 PKNOX2 ARNT SMARCA2 LRP5 MACF1 MYO16 | 4.31e-04 | 1275 | 245 | 23 | EFO_0004908 |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 4.97e-04 | 19 | 245 | 3 | DOID:4928 (is_marker_for) | |
| Disease | colorectal cancer (is_implicated_in) | 5.35e-04 | 121 | 245 | 6 | DOID:9256 (is_implicated_in) | |
| Disease | reticulocyte measurement | ASH1L TNRC6B TSC22D2 BIRC6 ZEB2 EHD4 BLVRB PTPRJ ARHGAP21 HECTD4 BRD3 REST FOXP4 SLC12A2 MEGF9 ANGPTL4 RCL1 LRP5 AKAP13 GAA | 5.43e-04 | 1053 | 245 | 20 | EFO_0010700 |
| Disease | neutrophil count | ACAP1 LIN54 UBQLN4 ASH1L CDH23 EHD4 MET ADRB2 PTPRJ SQSTM1 PLCB2 FGFR4 USP53 PRUNE2 HNF1A TTC28 HECTD4 BRD3 REST LCT SBNO1 LRP4 AKAP13 GABPB1 | 5.55e-04 | 1382 | 245 | 24 | EFO_0004833 |
| Disease | brain connectivity measurement | ADGRV1 TSC22D2 MET KCNK2 WNK2 FAT3 MLLT10 DACH2 ROBO2 ATF1 MYO16 | 5.60e-04 | 400 | 245 | 11 | EFO_0005210 |
| Disease | neuroimaging measurement | DDAH1 TNRC6B TSC22D2 PMEPA1 MAPK8IP3 KCNK2 PKHD1 FGFR3 WNK2 PODXL FAT3 RNF34 MLLT10 SBNO1 SMARCA2 MACF1 ROBO2 QSER1 RAPGEF2 MYO16 | 6.55e-04 | 1069 | 245 | 20 | EFO_0004346 |
| Disease | aspartate aminotransferase, cytoplasmic measurement | 6.75e-04 | 5 | 245 | 2 | EFO_0008031 | |
| Disease | bone disease (implicated_via_orthology) | 6.75e-04 | 5 | 245 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Thymoma | 6.75e-04 | 5 | 245 | 2 | C0040100 | |
| Disease | snoring measurement | 6.86e-04 | 84 | 245 | 5 | EFO_0008341 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 7.33e-04 | 49 | 245 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | feeling nervous measurement | 8.05e-04 | 87 | 245 | 5 | EFO_0009597 | |
| Disease | body fat percentage | POU6F2 TSC22D2 PMEPA1 TRIM66 HOXC6 PKHD1 PRRC2B KIF27 BRD3 MLLT10 TET1 MACF1 | 8.49e-04 | 488 | 245 | 12 | EFO_0007800 |
| Disease | IGF-1 measurement | PDE4A ESR2 LIN54 SREBF2 PMEPA1 MAPK8IP3 TRIM66 SLC24A4 HNF1A GRM5 SBNO1 RCL1 | 8.49e-04 | 488 | 245 | 12 | EFO_0004627 |
| Disease | cortical surface area measurement | SP4 DDAH1 TNRC6B CUL9 ADGRV1 TSC22D2 PMEPA1 KCNK2 PKHD1 AGFG1 FGFR3 ARHGAP21 WNK2 PODXL FAT3 REST MDC1 MACF1 ROBO2 QSER1 CD180 MYO16 KDM1A | 8.90e-04 | 1345 | 245 | 23 | EFO_0010736 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | POU6F2 TSC22D2 PMEPA1 TRIM66 HOXC6 PKHD1 KIF27 MLLT10 TET1 MACF1 | 9.99e-04 | 364 | 245 | 10 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 1.01e-03 | 24 | 245 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | Attention deficit hyperactivity disorder | 1.01e-03 | 24 | 245 | 3 | C1263846 | |
| Disease | laryngeal carcinoma (is_marker_for) | 1.01e-03 | 6 | 245 | 2 | DOID:2600 (is_marker_for) | |
| Disease | pulmonary alveolar proteinosis (is_implicated_in) | 1.01e-03 | 6 | 245 | 2 | DOID:12120 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.02e-03 | 243 | 245 | 8 | EFO_0004612, EFO_0020944 | |
| Disease | cortical thickness | DDAH1 TNRC6B CUL9 ADGRV1 TSC22D2 MAPK8IP3 KCNK2 PKHD1 FGFR3 ARHGAP21 WNK2 FAT3 MLLT10 AP3M1 MEGF9 LRP4 MACF1 ROBO2 QSER1 MYO16 | 1.07e-03 | 1113 | 245 | 20 | EFO_0004840 |
| Disease | Neurodevelopmental Disorders | 1.09e-03 | 93 | 245 | 5 | C1535926 | |
| Disease | Neoplastic Cell Transformation | 1.10e-03 | 139 | 245 | 6 | C0007621 | |
| Disease | alcohol dependence measurement | 1.13e-03 | 55 | 245 | 4 | EFO_0007835 | |
| Disease | Squamous cell carcinoma of esophagus | 1.20e-03 | 95 | 245 | 5 | C0279626 | |
| Disease | reticulocyte count | NCOA6 ASH1L TNRC6B TSC22D2 BIRC6 SLC12A5 EHD4 BLVRB PTPRJ NFRKB HECTD4 BRD3 REST FOXP4 MEGF9 ANGPTL4 RCL1 LRP5 GAA | 1.24e-03 | 1045 | 245 | 19 | EFO_0007986 |
| Disease | Lymphatic Metastasis | 1.28e-03 | 26 | 245 | 3 | C0024232 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 1.28e-03 | 26 | 245 | 3 | EFO_0007870 | |
| Disease | RENAL CELL CARCINOMA, NONPAPILLARY | 1.40e-03 | 7 | 245 | 2 | 144700 | |
| Disease | dipeptidyl peptidase 2 measurement | 1.40e-03 | 7 | 245 | 2 | EFO_0020326 | |
| Disease | Nonpapillary renal cell carcinoma | 1.40e-03 | 7 | 245 | 2 | cv:CN074294 | |
| Disease | Thymic Carcinoma | 1.40e-03 | 7 | 245 | 2 | C0205969 | |
| Disease | retinal detachment | 1.40e-03 | 7 | 245 | 2 | EFO_0005773 | |
| Disease | metabolic syndrome | 1.47e-03 | 200 | 245 | 7 | EFO_0000195 | |
| Disease | aspartate aminotransferase measurement | SP4 BIRC6 HMCN2 PTPRJ FGFR4 WNK2 HNF1A KIF27 TTC28 HECTD4 RNF213 BRD3 MLLT10 LCT PKNOX2 ABCB11 AKAP13 | 1.56e-03 | 904 | 245 | 17 | EFO_0004736 |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 1.59e-03 | 28 | 245 | 3 | DOID:0050866 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.71e-03 | 103 | 245 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | suntan | 1.71e-03 | 103 | 245 | 5 | EFO_0004279 | |
| Disease | Crohn's disease (is_marker_for) | 1.76e-03 | 29 | 245 | 3 | DOID:8778 (is_marker_for) | |
| Disease | dual specificity protein phosphatase 13 isoform A measurement | 1.86e-03 | 8 | 245 | 2 | EFO_0801549 | |
| Disease | Syndactyly | 1.86e-03 | 8 | 245 | 2 | C0039075 | |
| Disease | neutrophil percentage of leukocytes | LIN54 CDH23 TNRC6B EHD4 ADRB2 SQSTM1 HNF1A BRD3 LCT SBNO1 RCL1 AKAP13 IL7R | 1.89e-03 | 610 | 245 | 13 | EFO_0007990 |
| Disease | risk-taking behaviour | UBQLN4 CDH23 CUL9 BIRC6 PMEPA1 SCAF4 SLC12A5 SLC24A4 PODXL REST GRM5 CCDC195 PBRM1 FARP1 LRP4 | 1.94e-03 | 764 | 245 | 15 | EFO_0008579 |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 1.95e-03 | 30 | 245 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.05e-03 | 157 | 245 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | Coronary Artery Disease | 2.11e-03 | 65 | 245 | 4 | C1956346 | |
| Disease | Coronary Arteriosclerosis | 2.11e-03 | 65 | 245 | 4 | C0010054 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.26e-03 | 160 | 245 | 6 | DOID:5844 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQTRVASPSQGQVGS | 321 | Q99569 | |
| FGSLSNLQVTQPTVG | 111 | P08708 | |
| GESEQTPNNLFVGVS | 41 | A8MT66 | |
| PVNGSSGNQSVRLVT | 6 | P08173 | |
| TLNSQQEGGVSASAP | 816 | Q8N944 | |
| QSGIAFQTASVGQPL | 1461 | Q68DN1 | |
| PETGQTAGQFQTRTA | 706 | P27540 | |
| PATGQNVNITLQSVG | 66 | Q96L91 | |
| SPQTVALTQATAAGQ | 3071 | Q96L91 | |
| QQGAASTEGAVLPSS | 1866 | Q9HCE0 | |
| VTLQGPTLNGTFAQS | 31 | P30411 | |
| AGTQQVAAVSSVSPA | 166 | Q15059 | |
| QGTVPSDNIDSQGRN | 391 | P07550 | |
| TAQQAAGSALGQILP | 1076 | Q9NR48 | |
| QPVQGQASTIIGNGD | 191 | Q92870 | |
| ATAVLLSAQGGPVQS | 16 | Q9BY76 | |
| QLGDQAQGSTHTPIN | 506 | Q86VW2 | |
| SDQNLSVPAISGGNV | 196 | Q8IW19 | |
| INPVSSAVNGEAQSS | 4331 | Q9NR09 | |
| NGNAQVNGPVISTVI | 496 | Q5T601 | |
| QTNVPGVFAAGDAVT | 456 | Q96NN9 | |
| SQSLSIGNQVGSPES | 411 | Q8NEB7 | |
| DSPAANGNISVQILG | 386 | Q6V0I7 | |
| LQIVATDGGNLQSPN | 761 | Q6V0I7 | |
| TDGGNLQSPNQAIVT | 766 | Q6V0I7 | |
| GAFSINPQTGQITVT | 3451 | Q6V0I7 | |
| LQAGLPANTTAVVGS | 251 | P22455 | |
| VAPQVSLLTQGGAAQ | 1001 | Q12802 | |
| GQPNISTVVIALNGD | 2561 | Q8WXG9 | |
| ATGQTGLTTLAQAVQ | 11 | P30043 | |
| TVSQGNATQLIAPAG | 1186 | Q68CP9 | |
| LATDASQVQGAAGSQ | 861 | O95342 | |
| GSADGQLSVLQPNTI | 431 | Q92560 | |
| ANGAAQSGVLTLNET | 331 | Q9Y2F9 | |
| VNGGQDNATPLIQAT | 601 | Q15027 | |
| LGTSSNNLGVPATEQ | 626 | Q5JTW2 | |
| SNVGDTLPTGQLSNI | 151 | Q9Y2T2 | |
| GTPNLSVIFNGLQNS | 231 | Q99467 | |
| NQVSIAGQPAGVESA | 181 | Q9H694 | |
| TLQGNGSQNGTESEP | 236 | Q96NX9 | |
| SVNENVGGGTAVVQV | 1536 | Q9H251 | |
| GTDTTGSVQPQIVAN | 701 | Q5H9R4 | |
| GADTVGSAQPQAVAN | 981 | Q5H9R4 | |
| HSAQPQIVAGSQGET | 1026 | Q5H9R4 | |
| PNANISGGSVVADLN | 1081 | Q06278 | |
| SIANGNPVNSELEAG | 261 | Q8NFF2 | |
| SAELASNPQGQGAAV | 256 | Q9Y2P8 | |
| GQNAAGPSADSVTEN | 531 | Q9HBD1 | |
| SLTGVDVSGTQGNQV | 791 | Q6ZP01 | |
| GGSSGSQLPQIQTDV | 361 | Q8IUH3 | |
| GNASSRTEAQVPNGQ | 261 | Q8NBR0 | |
| QSGADQSDLAQPGAV | 546 | Q9H0J4 | |
| SPIGDSTQVSNGGLQ | 236 | Q2KHR3 | |
| SDGPNTTAGIQVLQE | 616 | Q4ADV7 | |
| TANNGQTVTIPVQGI | 736 | Q08999 | |
| TNVGDQLPTGQLSVV | 151 | P53677 | |
| ALAQGGTLSIPSVQA | 286 | Q8NFP4 | |
| QGDVQPGTVTLVCSN | 1001 | P51610 | |
| IPENTSQSQVIGTEG | 161 | Q9ULC0 | |
| TGAQVQVAGDLLPNS | 131 | P57723 | |
| GTTTLAQQVSGPVNT | 91 | O00592 | |
| AQQVSGPVNTTVARG | 96 | O00592 | |
| SSGQNLNTPEGETLN | 921 | Q13127 | |
| PSVATVATGENGITQ | 46 | Q12913 | |
| QNGTGTPQVETNTSE | 71 | Q12913 | |
| GQDNQGTVTEGSSPA | 166 | Q86U86 | |
| QPGLGSQDVVSKAAN | 386 | Q15746 | |
| VIGPGSSSVAIQVQN | 146 | P41594 | |
| TAGPSANVIQASTQL | 2886 | Q8NEZ4 | |
| TGTSGIQTQARLPFN | 496 | Q6MZP7 | |
| TDQSVTPEAIAQGGQ | 1666 | Q14676 | |
| NVTNLEGGPGRQTTS | 61 | Q92731 | |
| QVGGNSQTESSLPGR | 186 | Q9UPT6 | |
| APSASTAAVIQNVTG | 901 | Q6P4R8 | |
| GQQTSVVQTPTSADG | 196 | Q9Y692 | |
| AITAENGNSISNGLP | 1741 | Q9Y6X6 | |
| GVAQQGVSLQPGTTQ | 626 | Q86Z02 | |
| PSLVVVSGGNSLNNL | 2846 | O95714 | |
| NVATGVSTQVLPGGQ | 3981 | Q8NDA2 | |
| NSGQGIQSTPIDNSA | 1926 | Q5HYC2 | |
| PVVAVGNQGNVLATS | 211 | O43525 | |
| VPISQSDGSAVAATN | 716 | Q9NR82 | |
| NANTESEVPGGQSVG | 441 | Q9NYF5 | |
| SVDGAIQQVVSSGGQ | 256 | Q06547 | |
| DGTQPFVLTSLSQGQ | 1006 | O75197 | |
| NAGIIPLGNTSNQIS | 126 | O95069 | |
| VGQQFGESVTEPGQT | 161 | P14091 | |
| GQSPATLQGAVSTDA | 56 | A0A1B0GUA6 | |
| SPAAGLNVGNATNVI | 151 | Q8N1V2 | |
| GVSQTTQINREGSPD | 376 | Q86VH2 | |
| ASVGLAPVVNGESNS | 446 | Q15154 | |
| VGATNAQDQPVTLGT | 336 | Q8NBP7 | |
| AQDQPVTLGTLGTNF | 341 | Q8NBP7 | |
| VPQGQQGLAVFTSES | 271 | P80217 | |
| DVTTTQLLQPNAGGF | 281 | A8MYZ0 | |
| QQAQSTGSAPVAPDE | 781 | P27815 | |
| ENNQISLTSLGPSQG | 121 | A6NFA0 | |
| GVPGAIVNVSSQCSQ | 126 | Q7Z4W1 | |
| SLSTAQLVQPSGGLQ | 196 | Q14005 | |
| QLVQPSGGLQASVIS | 201 | Q14005 | |
| TVVTSLAQGNGPVQV | 461 | Q16656 | |
| TNQLPAGLITTDGQQ | 171 | P25208 | |
| ASVGNSRPTGQQLES | 26 | Q15726 | |
| PLQQVTSGQGGVFTQ | 71 | B2RXH2 | |
| SQEAASPATVQSRQG | 271 | Q9C075 | |
| ELATSGGQSPTGEQI | 1711 | O94854 | |
| ITENGVGLTNPNTED | 1271 | P09848 | |
| DGNEVAPNGQLTLTT | 581 | Q9H1U4 | |
| VSPSQAQGLGSNLVT | 246 | P20823 | |
| SQEETSTPTQLVQGG | 401 | Q9H223 | |
| ASETIRSAPSGQNGV | 6 | Q8IVH2 | |
| VAQGQPILTSLGSNQ | 431 | P16871 | |
| NDDGTVQSSVAVGTP | 226 | Q9Y5S2 | |
| VVNQSLFDTQGSPGL | 3216 | Q9Y4D8 | |
| DVIVGSPLENQNSGA | 571 | P17301 | |
| QSRTSIVQAAAGGVP | 256 | Q9NR12 | |
| VGAADNSINLGSPEQ | 226 | Q9BRP4 | |
| GVNSTAAAAAGQPNV | 6 | Q969W9 | |
| GGSAEPSQTQNFILT | 96 | Q86Y26 | |
| GQQTDPLVAAAAVNS | 521 | Q14671 | |
| TIFANAGQVVTGNPT | 141 | Q96GM1 | |
| GGQDVLPNVALNSTA | 16 | P09630 | |
| QQTTLGGLFSQPTQA | 96 | Q7Z3B4 | |
| VSLSVQQETSNLGPG | 236 | O94913 | |
| LNPQNSTVSVAAVGG | 1396 | Q14686 | |
| NTDLSPQGVTGLENT | 101 | O43825 | |
| PQGVTGLENTLSANG | 106 | O43825 | |
| TSDNGAALISAPEQG | 286 | P34059 | |
| LDGQVNSGIAATPAS | 471 | Q969S8 | |
| VNISSPVTVNEGGNV | 136 | A6NGN9 | |
| IISPSNNGGNVQETV | 26 | Q86XP6 | |
| SENGSEVAAQPAGLS | 31 | O60341 | |
| VPVGASFASNTVGVQ | 171 | Q6AI39 | |
| VQAGTSSPGDAQESV | 1251 | Q6ZP82 | |
| GQSQPNGQSVAVTGA | 791 | A0AVK6 | |
| SELSVNSQGGVAPAN | 481 | Q9Y4F1 | |
| LINGGESAPTTLTQQ | 1341 | P02751 | |
| TITGFQVDAVPANGQ | 1931 | P02751 | |
| GGTPALSAVATVNIN | 3316 | Q8TDW7 | |
| SLSAQDLQTVAGQGT | 461 | Q00597 | |
| PGAGQEVQTENVTVA | 21 | Q8NFZ8 | |
| QSPSQEAAGEAVLGA | 916 | P00519 | |
| GARVQQNVPSGTDTG | 31 | O14791 | |
| FGNSSQVGINLPTGE | 1816 | Q0VDD8 | |
| SNQPEGVSINVIAGG | 3711 | Q99698 | |
| VLGVATAPQQVLSNG | 906 | P10253 | |
| AGAQEGTQEPAATVA | 546 | Q9Y2E5 | |
| SSPGAVGAEQTQALL | 1481 | O60336 | |
| QDGVIVTTAAGNPLQ | 866 | Q9P267 | |
| GNFIISTDPNTNEGV | 401 | Q08554 | |
| GTQGSPVEVQEAGTQ | 166 | Q587J8 | |
| QNITSPDAEGVSALG | 1381 | Q8IWT3 | |
| AVNEGGQSQPSALDT | 921 | Q86VF2 | |
| LQPGDSVIQNASNSG | 181 | Q9BV79 | |
| QVPQSTQEVSGAGRD | 751 | Q96PD2 | |
| QAGLPANQTAVLGSD | 256 | P22607 | |
| ALQGPTAAQVLQAGV | 181 | P48728 | |
| PVLVNVTQGCAGDNS | 876 | P82279 | |
| GPGSSSVAIQVQNLL | 161 | Q13255 | |
| SEAGVSVQQGAASLP | 106 | Q8IYL3 | |
| GQPTDAASSVADGIQ | 11 | D6RIA3 | |
| GQNSIPALAQVSVAG | 31 | Q03060 | |
| HNNVTSIQGIPGLAS | 426 | Q9UHW9 | |
| AGTSNAAPVAENVTN | 136 | O95104 | |
| AHSITSPGGNNVQLI | 581 | Q92503 | |
| STVNGAVQLPNGNLV | 346 | Q8WUM9 | |
| AQPVATAATDVSNGT | 176 | A3KN83 | |
| TSQGQVVTQAIPQGA | 251 | Q96KN3 | |
| AGPNLIAIGSSESAQ | 181 | O94760 | |
| NTQPGTENLLINVSG | 261 | P15509 | |
| KTPQENGATAGSGVQ | 261 | O15120 | |
| QGGLTDQSVPGAQTV | 526 | Q9P2P1 | |
| NNVTEIQGIPGAASG | 361 | Q9H2X9 | |
| ASLAGAQIVQTGANT | 196 | P23511 | |
| HNATGQGNISISLVP | 136 | O95157 | |
| PVEEAANTTGGLANA | 426 | Q9GZU5 | |
| QPDQNFTGLIAGVVS | 926 | P08581 | |
| LEGQGPANTQDATIA | 136 | Q8N8U3 | |
| VQPQLVLGGAAQTAS | 546 | O00268 | |
| TGPGQAAENVTIQTV | 106 | A6NDD5 | |
| PNLQTVSVANLGAAG | 531 | Q02446 | |
| ANATIGAVSPDQLTQ | 586 | Q02446 | |
| NDLGPAGTVDSSQGQ | 271 | Q9NQ40 | |
| EPSEINGDNSTGLQV | 2191 | Q8WUY3 | |
| GQDVQGTSVIANLPF | 66 | Q6NUP7 | |
| VPSNSQLEIEGNSSG | 1406 | P51531 | |
| TTQAGNSSEQAIPQA | 306 | P07988 | |
| QAQVPVGLDQSEGAS | 581 | Q5TGY1 | |
| NSTGNIFDELPVTNG | 211 | Q9P0V3 | |
| NGRVSQITQPGTSGQ | 371 | P32745 | |
| TLNNVGDAETPGTVS | 71 | O75157 | |
| GKAVATAAQAQTGPE | 851 | Q13428 | |
| NGVAVGQQPSTGLSD | 551 | P22670 | |
| GQQPSTGLSDISAQV | 556 | P22670 | |
| LVQESTGGNSQVAGA | 406 | Q9BXS9 | |
| SSQAASGTQGLQVQP | 356 | P78424 | |
| SVGQLVSNPQTAAGE | 461 | P78424 | |
| VSNPQTAAGEVDGVN | 466 | P78424 | |
| TQTQVGQALSATEGP | 501 | P78424 | |
| TSQAGTNQSGISQPV | 366 | Q86VE3 | |
| EGTDSSQGIPQLVSN | 11 | Q99832 | |
| NVTVSQADSGTARPG | 711 | P08F94 | |
| TTVNSVLPQNSVLGG | 571 | Q8NCN4 | |
| SAVPTGSQIANIGQQ | 721 | Q15714 | |
| GQQTSALQTAGISGE | 1586 | Q9UHV7 | |
| PGGNVEGATQSLAEQ | 296 | Q13501 | |
| TSQGNPSIQLEELGS | 261 | Q8NFU7 | |
| QNSNLSVEVGSEGPL | 706 | Q9UM73 | |
| SPAQQGSGVSGVQQV | 856 | P55197 | |
| VTPFGQVAAAGVSSN | 526 | P52594 | |
| QNGTVLPSESAGLAT | 1916 | Q8IWZ3 | |
| ASPGTDGVQGLQTLT | 121 | P18846 | |
| TTVSQQGAELLNSGT | 271 | Q6ZVT6 | |
| QNGDTPEAQGLDITT | 601 | Q15003 | |
| FQQQTGGVPESSLAG | 86 | P55854 | |
| NGSTNLDSPVIDGNG | 696 | Q70EK8 | |
| AIAAVTGQGQNPNAT | 1566 | Q7KZ85 | |
| QGSTNATVLDVAQTG | 936 | Q9Y4G8 | |
| SEPGTELQTTEQQAG | 251 | Q63HN8 | |
| EAPSEQTLSAQGVSQ | 76 | Q6P9A3 | |
| AVGQQEGSHGLPQST | 671 | Q2QGD7 | |
| SQELPAQTGLLSQTG | 186 | Q6ZSR9 | |
| SINGNPIVSVNTFTG | 3196 | Q8IZQ1 | |
| ISSGSQGAQGQALDV | 1956 | Q99973 | |
| QAQGESPAANEGTTV | 2361 | Q96T58 | |
| VNATVGTVNAAPGTV | 2711 | Q96T58 | |
| SGVPAQVQSEITSAN | 206 | Q969K3 | |
| LINVAGAGTPAISTN | 276 | Q9NXZ1 | |
| NVVLATNTGASADGP | 346 | P38935 | |
| LVGVSDPNSQAGQQG | 1446 | Q9Y490 | |
| IGGSSFPGQTQVVAN | 241 | Q02447 | |
| GTFLIQAQTVTPSGQ | 446 | Q02447 | |
| GPNVSFQNGGDTVLS | 166 | P55011 | |
| ANGTLQTLAPATVQT | 216 | Q12772 | |
| AQAPNSAITAQTGVG | 521 | Q9H0E3 | |
| QQGLSNASTEGPVAD | 51 | O00624 | |
| ESVVNFTGGQEPTQS | 216 | O15015 | |
| GVQSGTPITNDLFSQ | 306 | Q96S82 | |
| QISVSQGAGVSRQAP | 1046 | Q12968 | |
| TQSISQENTNSVPGG | 126 | Q5JSZ5 | |
| ANNGSVLQGTSVASV | 321 | Q15166 | |
| LQGPANQTLAVDGTA | 421 | Q9HCK4 | |
| GLVQEAAQPQGSTSE | 66 | Q9NPB0 | |
| VSVQTTDQSLQAGGQ | 181 | Q15853 | |
| VGDVQGQESESQLPT | 676 | Q96JH7 | |
| VASQVNGALAPTSNG | 851 | Q00722 | |
| ADLTGVTVQSPGEAQ | 321 | O00220 | |
| TSAIITNDGIGINPA | 46 | P61960 | |
| RGSGAQQSATVANPV | 21 | Q6ZN44 | |
| QETINASPIQQGGHS | 441 | P37275 | |
| PALSEGISLQGQVTQ | 101 | O43296 | |
| GISLQGQVTQGNSVD | 106 | O43296 | |
| NNPEDGVQAPSSTAV | 2191 | Q96AY4 | |
| STEEQSAGLQQPSGI | 1161 | Q9H6S0 | |
| TGGATSQIQGVQTND | 451 | Q9NS56 | |
| VLQTSSTGNEAGGVN | 1186 | Q15643 | |
| VQEPSAGTSSLAVQG | 316 | Q6ZT12 | |
| TLPQVGNSGDQAGAT | 206 | Q9P0L1 | |
| PNSGIIDAGASINVS | 56 | O95292 | |
| GQRQSSSEIEATQGP | 741 | Q8NEE8 | |
| SSQLIPEESGAVGNN | 141 | Q5QJ38 | |
| GTGEESRQSQANAPV | 1286 | Q9Y3S1 | |
| GPEATIQTAINNGTV | 121 | O60315 | |
| NSDTETVIQAAGGVP | 166 | Q9Y462 | |
| IQSVSNLTAGAPQAV | 656 | O15016 | |
| GQDETLENVNSGTPI | 501 | Q5T5U3 | |
| IQLLAGSGNSQVQTP | 541 | Q9NRR5 | |
| NPGSATSNVAISVDQ | 306 | Q8IYM9 | |
| AGITQAPTSQILAAG | 21 | A0A1B0GX49 | |
| NVSDNAGVQGSPLVN | 1151 | Q6BDS2 | |
| EQVGGPSLTSDLQAQ | 91 | P04004 | |
| NSIVIQVPALGDSSG | 521 | Q03167 | |
| NAQVTGALLQSESGT | 136 | Q9UPQ9 | |
| AIANAISVVSSNGPG | 961 | O95071 | |
| PSNTGEVNFQSGIIA | 686 | P35573 | |
| NQTNVTEEGTQSIPG | 1781 | Q14789 | |
| LTSGSVFPQQTGQLA | 21 | P81172 | |
| VSPQRQTGTNACGVN | 1606 | O75096 |